Recent advances in nanomaterial-based synergistic combination cancer immunotherapy

In recent years, conventional treatments including surgery, chemotherapy and radiotherapy have been the main approaches in tumour therapy. Cancer immunotherapy is a new therapeutic modality to fight cancer by harnessing the power of patients' own immune system. Ongoing research related to these...

Full description

Saved in:
Bibliographic Details
Published inChemical Society reviews Vol. 48; no. 14; pp. 3771 - 381
Main Authors Sang, Wei, Zhang, Zhan, Dai, Yunlu, Chen, Xiaoyuan
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 15.07.2019
Subjects
Anticancer properties
antineoplastic activity
biocompatible materials
bioengineering
Biomedical materials
Cancer therapies
Chemotherapy
Combined Modality Therapy
drug therapy
Humans
immune system
Immunotherapy
Materials science
metastasis
Nanomaterials
Nanostructures - chemistry
neoplasms
Neoplasms - immunology
Neoplasms - therapy
patients
precision medicine
Radiation therapy
radiotherapy
surgery
Transformations
Online AccessGet full text

Cover

Abstract In recent years, conventional treatments including surgery, chemotherapy and radiotherapy have been the main approaches in tumour therapy. Cancer immunotherapy is a new therapeutic modality to fight cancer by harnessing the power of patients' own immune system. Ongoing research related to these therapies has demonstrated their advantages and intrinsic limitations. Nanomaterial-based platforms are utilized in these emerging fields. In particular, a combination of other treatment methods with cancer immunotherapy to achieve precision medicine and prevent recurrence and metastasis, could improve patients' outcome. The combined multiple treatments have superior efficacy to any monotherapy alone in producing improved anti-cancer activity. Therefore, it's necessary to summarise research advances in nanomaterial-based combination cancer immunotherapy contributing to clinical transformation. This review is based on the principles of cancer immunotherapy and the combined treatment design reflected by advances in materials science, including the structures of nanoplatforms and their underlying mechanisms towards cancer. The ultimate goals are to stimulate the design of better strategies for versatile use in the future based on biomaterial engineering methods to enhance the efficacy of combined cancer treatments, and to provide new ideas for the prospects of a synergistic cancer combination immunotherapy for clinical application transformation. This review aims to summarize various synergistic combination cancer immunotherapy strategies based on nanomaterials.
AbstractList In recent years, conventional treatments including surgery, chemotherapy and radiotherapy have been the main approaches in tumour therapy. Cancer immunotherapy is a new therapeutic modality to fight cancer by harnessing the power of patients' own immune system. Ongoing research related to these therapies has demonstrated their advantages and intrinsic limitations. Nanomaterial-based platforms are utilized in these emerging fields. In particular, a combination of other treatment methods with cancer immunotherapy to achieve precision medicine and prevent recurrence and metastasis, could improve patients' outcome. The combined multiple treatments have superior efficacy to any monotherapy alone in producing improved anti-cancer activity. Therefore, it's necessary to summarise research advances in nanomaterial-based combination cancer immunotherapy contributing to clinical transformation. This review is based on the principles of cancer immunotherapy and the combined treatment design reflected by advances in materials science, including the structures of nanoplatforms and their underlying mechanisms towards cancer. The ultimate goals are to stimulate the design of better strategies for versatile use in the future based on biomaterial engineering methods to enhance the efficacy of combined cancer treatments, and to provide new ideas for the prospects of a synergistic cancer combination immunotherapy for clinical application transformation.
In recent years, conventional treatments including surgery, chemotherapy and radiotherapy have been the main approaches in tumour therapy. Cancer immunotherapy is a new therapeutic modality to fight cancer by harnessing the power of patients' own immune system. Ongoing research related to these therapies has demonstrated their advantages and intrinsic limitations. Nanomaterial-based platforms are utilized in these emerging fields. In particular, a combination of other treatment methods with cancer immunotherapy to achieve precision medicine and prevent recurrence and metastasis, could improve patients' outcome. The combined multiple treatments have superior efficacy to any monotherapy alone in producing improved anti-cancer activity. Therefore, it's necessary to summarise research advances in nanomaterial-based combination cancer immunotherapy contributing to clinical transformation. This review is based on the principles of cancer immunotherapy and the combined treatment design reflected by advances in materials science, including the structures of nanoplatforms and their underlying mechanisms towards cancer. The ultimate goals are to stimulate the design of better strategies for versatile use in the future based on biomaterial engineering methods to enhance the efficacy of combined cancer treatments, and to provide new ideas for the prospects of a synergistic cancer combination immunotherapy for clinical application transformation. This review aims to summarize various synergistic combination cancer immunotherapy strategies based on nanomaterials.
In recent years, conventional treatments including surgery, chemotherapy and radiotherapy have been the main approaches in tumour therapy. Cancer immunotherapy is a new therapeutic modality to fight cancer by harnessing the power of patients' own immune system. Ongoing research related to these therapies has demonstrated their advantages and intrinsic limitations. Nanomaterial-based platforms are utilized in these emerging fields. In particular, a combination of other treatment methods with cancer immunotherapy to achieve precision medicine and prevent recurrence and metastasis, could improve patients' outcome. The combined multiple treatments have superior efficacy to any monotherapy alone in producing improved anti-cancer activity. Therefore, it's necessary to summarise research advances in nanomaterial-based combination cancer immunotherapy contributing to clinical transformation. This review is based on the principles of cancer immunotherapy and the combined treatment design reflected by advances in materials science, including the structures of nanoplatforms and their underlying mechanisms towards cancer. The ultimate goals are to stimulate the design of better strategies for versatile use in the future based on biomaterial engineering methods to enhance the efficacy of combined cancer treatments, and to provide new ideas for the prospects of a synergistic cancer combination immunotherapy for clinical application transformation.In recent years, conventional treatments including surgery, chemotherapy and radiotherapy have been the main approaches in tumour therapy. Cancer immunotherapy is a new therapeutic modality to fight cancer by harnessing the power of patients' own immune system. Ongoing research related to these therapies has demonstrated their advantages and intrinsic limitations. Nanomaterial-based platforms are utilized in these emerging fields. In particular, a combination of other treatment methods with cancer immunotherapy to achieve precision medicine and prevent recurrence and metastasis, could improve patients' outcome. The combined multiple treatments have superior efficacy to any monotherapy alone in producing improved anti-cancer activity. Therefore, it's necessary to summarise research advances in nanomaterial-based combination cancer immunotherapy contributing to clinical transformation. This review is based on the principles of cancer immunotherapy and the combined treatment design reflected by advances in materials science, including the structures of nanoplatforms and their underlying mechanisms towards cancer. The ultimate goals are to stimulate the design of better strategies for versatile use in the future based on biomaterial engineering methods to enhance the efficacy of combined cancer treatments, and to provide new ideas for the prospects of a synergistic cancer combination immunotherapy for clinical application transformation.
Author Zhang, Zhan
Chen, Xiaoyuan
Sang, Wei
Dai, Yunlu
AuthorAffiliation Cancer Centre
Laboratory of Molecular Imaging and Nanomedicine
Institute of Translational Medicine
National Institutes of Health
University of Macau
Faculty of Health Sciences
National Institute of Biomedical Imaging and Bioengineering
AuthorAffiliation_xml – sequence: 0
  name: National Institute of Biomedical Imaging and Bioengineering
– sequence: 0
  name: Cancer Centre
– sequence: 0
  name: Faculty of Health Sciences
– sequence: 0
  name: Institute of Translational Medicine
– sequence: 0
  name: University of Macau
– sequence: 0
  name: Laboratory of Molecular Imaging and Nanomedicine
– sequence: 0
  name: National Institutes of Health
Author_xml – sequence: 1
  givenname: Wei
  surname: Sang
  fullname: Sang, Wei
– sequence: 2
  givenname: Zhan
  surname: Zhang
  fullname: Zhang, Zhan
– sequence: 3
  givenname: Yunlu
  surname: Dai
  fullname: Dai, Yunlu
– sequence: 4
  givenname: Xiaoyuan
  surname: Chen
  fullname: Chen, Xiaoyuan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31165801$$D View this record in MEDLINE/PubMed
BookMark eNqN0ktrGzEUBWBREhrH7ab7loFuQmBSvSxplsHkBYGAk64HPe60CjOSK2kK_vcZx04LIYuspMV3LuhcHaODEAMg9IXgM4JZ88MqmzFWjYAPaEa4wDWXnB-gGWZY1BgTeoSOc36cbkQK-hEdMULEQmEyQ6sVWAil0u6vDhZy5UMVdIiDLpC87mujM7gqbwKkXz4XbysbB-ODLj6Gym5DqfLDMIZYfkPS680ndNjpPsPn_TlHPy8vHpbX9e3d1c3y_La2nIlSgzFNRwxtFDeGOCmYcNpSTow0kmPqnOuc0M4RYY0Q1soGg-OUU9dJ7Bybo5Pd3HWKf0bIpR18ttD3OkAcc0upEoqrhsp30IUiC8XYYqLfX9HHOKYwPWSrpJyqm-Acfdur0Qzg2nXyg06b9qXYCeAdsCnmnKBrrS_PnZWkfd8S3G531y7V8v55dxdT5PRV5GXqm_jrDqds_7n_H4E9AX-To44
CitedBy_id crossref_primary_10_1002_adfm_202100386
crossref_primary_10_1002_adma_202211130
crossref_primary_10_3390_biomedicines12010202
crossref_primary_10_1002_anie_202005309
crossref_primary_10_1038_s41598_020_76297_7
crossref_primary_10_1126_scitranslmed_aba9772
crossref_primary_10_1186_s40824_023_00405_7
crossref_primary_10_1016_j_jconrel_2021_10_026
crossref_primary_10_1002_ange_202100441
crossref_primary_10_1039_C9NR06558J
crossref_primary_10_1002_adma_202300086
crossref_primary_10_1002_anie_202008386
crossref_primary_10_1039_D2CC04420J
crossref_primary_10_1186_s12951_022_01373_1
crossref_primary_10_1016_j_addr_2021_113905
crossref_primary_10_1039_D2TB01200F
crossref_primary_10_1039_D1CS01138C
crossref_primary_10_1002_VIW_20200133
crossref_primary_10_1039_D2NA00222A
crossref_primary_10_2139_ssrn_4067999
crossref_primary_10_1016_j_ccr_2023_215430
crossref_primary_10_1002_nano_202300055
crossref_primary_10_1039_D2BM01698B
crossref_primary_10_1007_s12274_021_3977_8
crossref_primary_10_1039_D2NR07071E
crossref_primary_10_1177_08853282211027882
crossref_primary_10_1016_j_jconrel_2021_10_015
crossref_primary_10_1002_adfm_202410113
crossref_primary_10_1038_s41551_022_00846_w
crossref_primary_10_1021_acsnano_2c06026
crossref_primary_10_1021_acsnano_0c06765
crossref_primary_10_1016_j_cej_2020_126801
crossref_primary_10_1021_jacs_3c08622
crossref_primary_10_1002_smtd_202201083
crossref_primary_10_1021_acsnano_1c08237
crossref_primary_10_3389_fimmu_2021_725204
crossref_primary_10_1039_D4TB01142B
crossref_primary_10_1016_j_jconrel_2022_08_025
crossref_primary_10_1021_jacs_3c08181
crossref_primary_10_1021_acsnano_1c10565
crossref_primary_10_1002_sstr_202000068
crossref_primary_10_1021_jacs_3c07097
crossref_primary_10_1038_s41598_020_76778_9
crossref_primary_10_1021_acsami_3c16571
crossref_primary_10_1016_j_apsb_2023_03_004
crossref_primary_10_1021_acsami_3c13188
crossref_primary_10_1021_acs_molpharmaceut_3c00846
crossref_primary_10_1016_j_jcis_2022_08_125
crossref_primary_10_1016_j_inoche_2024_112483
crossref_primary_10_1002_smll_202102557
crossref_primary_10_3389_fbioe_2020_612950
crossref_primary_10_1002_adma_201906783
crossref_primary_10_1002_adhm_202101375
crossref_primary_10_1016_j_cej_2021_130111
crossref_primary_10_1007_s13399_023_04769_7
crossref_primary_10_1039_D0TB02294B
crossref_primary_10_1039_D3NJ02067C
crossref_primary_10_1016_j_procbio_2020_09_010
crossref_primary_10_1016_j_ajps_2024_100912
crossref_primary_10_1021_acsami_2c14433
crossref_primary_10_3389_fonc_2022_835603
crossref_primary_10_1002_adhm_202302016
crossref_primary_10_1016_j_dyepig_2020_108599
crossref_primary_10_1002_adhm_202201233
crossref_primary_10_1016_j_biomaterials_2022_121528
crossref_primary_10_1016_j_ejpb_2022_03_002
crossref_primary_10_1016_j_nantod_2023_102061
crossref_primary_10_1039_C9QM00667B
crossref_primary_10_1016_j_talanta_2021_122225
crossref_primary_10_1016_j_procbio_2021_03_018
crossref_primary_10_1039_D3TB02842A
crossref_primary_10_1002_smll_202003508
crossref_primary_10_1039_C9NR09402D
crossref_primary_10_1016_j_matt_2020_08_027
crossref_primary_10_1007_s12668_023_01065_6
crossref_primary_10_1021_acsabm_3c00826
crossref_primary_10_1021_acs_nanolett_1c03243
crossref_primary_10_1039_D1TB00453K
crossref_primary_10_1016_j_ccr_2019_213022
crossref_primary_10_1016_j_ccr_2021_214009
crossref_primary_10_1039_C9CC07968H
crossref_primary_10_1039_D0CC01856B
crossref_primary_10_1002_adhm_202201884
crossref_primary_10_1021_acsabm_1c00633
crossref_primary_10_1016_j_biomaterials_2024_122481
crossref_primary_10_1002_smtd_202400510
crossref_primary_10_1002_viw2_19
crossref_primary_10_1021_acsami_1c25072
crossref_primary_10_1038_s41568_022_00496_9
crossref_primary_10_1186_s12943_023_01797_9
crossref_primary_10_1002_adma_202208553
crossref_primary_10_1016_j_actbio_2024_10_013
crossref_primary_10_1021_acsami_1c11485
crossref_primary_10_1016_j_biopha_2023_114976
crossref_primary_10_34133_bmr_0151
crossref_primary_10_1007_s12274_020_2904_8
crossref_primary_10_1016_j_biomaterials_2021_120992
crossref_primary_10_1021_acsabm_0c00394
crossref_primary_10_1016_j_pnsc_2020_09_016
crossref_primary_10_1186_s12951_022_01691_4
crossref_primary_10_3390_nano12111798
crossref_primary_10_1016_j_biomaterials_2020_120455
crossref_primary_10_1016_j_ijbiomac_2025_139927
crossref_primary_10_1016_j_cej_2022_140466
crossref_primary_10_1039_D1SC04112F
crossref_primary_10_1002_adtp_201900215
crossref_primary_10_1016_j_addr_2022_114296
crossref_primary_10_1002_adfm_202407153
crossref_primary_10_1016_j_cclet_2021_04_036
crossref_primary_10_1038_s41467_022_33831_7
crossref_primary_10_1016_j_bea_2023_100082
crossref_primary_10_1039_D1RA00093D
crossref_primary_10_2139_ssrn_4199982
crossref_primary_10_1186_s12951_025_03254_9
crossref_primary_10_1016_j_bios_2022_114880
crossref_primary_10_1016_j_ejmech_2021_113251
crossref_primary_10_1016_j_matt_2022_02_019
crossref_primary_10_1039_D0PY00431F
crossref_primary_10_1080_10717544_2021_1966129
crossref_primary_10_1016_j_jconrel_2023_12_007
crossref_primary_10_1186_s13048_023_01260_9
crossref_primary_10_1016_j_semcancer_2022_02_016
crossref_primary_10_1021_acsmaterialslett_2c01093
crossref_primary_10_1039_D1SC02154K
crossref_primary_10_1016_j_cej_2021_129037
crossref_primary_10_1038_s41401_020_0448_9
crossref_primary_10_1016_j_actbio_2020_07_063
crossref_primary_10_1039_D0BM00395F
crossref_primary_10_1021_acsnano_1c02103
crossref_primary_10_1155_2020_1346045
crossref_primary_10_1016_j_cej_2023_142962
crossref_primary_10_1016_j_ccr_2023_215615
crossref_primary_10_1021_acsomega_4c10865
crossref_primary_10_1002_advs_202203353
crossref_primary_10_1021_acsnano_3c10174
crossref_primary_10_1002_adfm_202419395
crossref_primary_10_1016_j_bios_2020_112787
crossref_primary_10_1002_adhm_202402272
crossref_primary_10_1002_chem_202400425
crossref_primary_10_1039_D2NR02012B
crossref_primary_10_1186_s12951_022_01531_5
crossref_primary_10_1515_nanoph_2021_0205
crossref_primary_10_1002_adma_202003214
crossref_primary_10_1021_acs_biomac_1c00244
crossref_primary_10_1002_adma_202207391
crossref_primary_10_1039_D0CS00178C
crossref_primary_10_1002_smll_202308861
crossref_primary_10_15541_jim20220194
crossref_primary_10_1002_smll_202401397
crossref_primary_10_1021_acsami_0c14855
crossref_primary_10_1039_D2SC06435A
crossref_primary_10_1002_adma_202103505
crossref_primary_10_3390_cancers14153698
crossref_primary_10_1002_ijc_34256
crossref_primary_10_1039_D2BM00216G
crossref_primary_10_1002_adhm_202202135
crossref_primary_10_1002_mco2_187
crossref_primary_10_1021_acsami_2c12503
crossref_primary_10_1002_smll_202005064
crossref_primary_10_1016_j_cej_2020_124314
crossref_primary_10_1002_smll_202100314
crossref_primary_10_1016_j_trac_2021_116309
crossref_primary_10_1039_C9CC05691B
crossref_primary_10_1002_adfm_202104472
crossref_primary_10_2147_IJN_S455936
crossref_primary_10_1021_acsnano_2c11691
crossref_primary_10_1021_acsami_3c05861
crossref_primary_10_1002_EXP_20220173
crossref_primary_10_1016_j_nantod_2022_101656
crossref_primary_10_1002_adtp_202100130
crossref_primary_10_1016_j_molliq_2020_112962
crossref_primary_10_1016_j_apmt_2021_101149
crossref_primary_10_1016_j_jconrel_2023_01_078
crossref_primary_10_1039_C9NR06222J
crossref_primary_10_1038_s41467_022_35709_0
crossref_primary_10_31083_j_fbl2702040
crossref_primary_10_1002_ange_202008386
crossref_primary_10_1016_j_jconrel_2022_09_015
crossref_primary_10_1016_j_jddst_2023_105184
crossref_primary_10_1016_j_cclet_2023_108180
crossref_primary_10_1021_acsmaterialslett_0c00377
crossref_primary_10_1021_acs_nanolett_9b05210
crossref_primary_10_1038_s41392_022_01243_0
crossref_primary_10_1002_advs_202105894
crossref_primary_10_1021_acs_accounts_3c00122
crossref_primary_10_1021_acsanm_3c00764
crossref_primary_10_1039_D1TB02719K
crossref_primary_10_1186_s12951_021_00936_y
crossref_primary_10_1038_s41392_023_01668_1
crossref_primary_10_1002_ange_202005309
crossref_primary_10_1002_lpor_202300565
crossref_primary_10_1038_s41467_022_31932_x
crossref_primary_10_1039_C9MH01725A
crossref_primary_10_1002_adfm_202100452
crossref_primary_10_1021_acsnano_4c12261
crossref_primary_10_1186_s12951_021_00782_y
crossref_primary_10_1016_j_ccr_2022_214427
crossref_primary_10_1002_VIW_20200075
crossref_primary_10_3389_fchem_2020_596658
crossref_primary_10_1016_j_apsb_2022_06_008
crossref_primary_10_1016_j_bioactmat_2022_08_028
crossref_primary_10_1007_s40820_019_0292_y
crossref_primary_10_1016_j_biomaterials_2019_119738
crossref_primary_10_1039_D2OB00571A
crossref_primary_10_1002_anie_202100441
crossref_primary_10_1039_D1TB00155H
crossref_primary_10_1039_D1BM01161H
crossref_primary_10_2174_1568009621666210219101552
crossref_primary_10_1021_acsami_2c12774
crossref_primary_10_1002_slct_202403554
crossref_primary_10_1002_smll_202206911
crossref_primary_10_1038_s41578_023_00617_2
crossref_primary_10_1039_D1TB01001H
crossref_primary_10_1177_08853282231162111
crossref_primary_10_1021_acsbiomaterials_2c00171
crossref_primary_10_1002_adfm_202008061
crossref_primary_10_1039_D2CS00247G
crossref_primary_10_1007_s12274_020_3265_z
crossref_primary_10_1039_C9NR09713A
crossref_primary_10_1021_acsami_2c18244
crossref_primary_10_1021_acsami_1c04305
crossref_primary_10_2147_IJN_S295445
crossref_primary_10_1002_adfm_202000335
crossref_primary_10_1016_j_apsb_2022_09_017
crossref_primary_10_1021_acs_nanolett_2c00349
crossref_primary_10_1016_j_phrs_2019_104438
crossref_primary_10_1021_acsnano_3c09011
crossref_primary_10_1016_j_procbio_2021_01_018
crossref_primary_10_1016_j_gce_2022_06_006
crossref_primary_10_1039_D4BM01399A
crossref_primary_10_1039_D1QM00141H
crossref_primary_10_1016_j_apsb_2020_12_018
crossref_primary_10_1021_acsami_3c08936
crossref_primary_10_1002_adma_202200449
crossref_primary_10_1002_advs_202003338
crossref_primary_10_1021_acsnano_1c08026
crossref_primary_10_1002_adhm_202101199
crossref_primary_10_1007_s12274_022_4474_4
crossref_primary_10_1039_D1TB02524D
crossref_primary_10_1016_j_nantod_2024_102219
crossref_primary_10_1016_j_trac_2022_116531
crossref_primary_10_1016_j_ccr_2024_216140
crossref_primary_10_1039_D0QM00786B
crossref_primary_10_1002_adma_202106768
crossref_primary_10_1002_adfm_202104325
crossref_primary_10_1016_j_colsurfa_2022_130521
crossref_primary_10_1016_j_mattod_2024_07_013
crossref_primary_10_1016_j_smaim_2024_08_002
crossref_primary_10_1002_EXP_20240037
crossref_primary_10_1016_j_biopha_2023_114567
crossref_primary_10_1002_adtp_202000110
crossref_primary_10_1038_s41467_024_55575_2
crossref_primary_10_1002_smll_202303517
crossref_primary_10_1016_j_jconrel_2020_07_018
crossref_primary_10_1039_D1NR06512B
crossref_primary_10_1080_10717544_2022_2095058
crossref_primary_10_1016_j_jconrel_2024_01_049
crossref_primary_10_1002_sstr_202000026
crossref_primary_10_1039_C9TB02199J
crossref_primary_10_1016_j_apmt_2021_101019
crossref_primary_10_1016_j_ejmech_2022_114236
crossref_primary_10_1016_j_nxnano_2023_100018
crossref_primary_10_1038_s41598_024_77592_3
crossref_primary_10_1039_D4CC02702G
crossref_primary_10_1007_s12274_020_3179_9
crossref_primary_10_1002_adma_201907953
crossref_primary_10_1002_adma_202202169
crossref_primary_10_1002_smll_202203659
crossref_primary_10_1016_j_smaim_2021_03_001
crossref_primary_10_1002_INMD_20220012
crossref_primary_10_1016_j_actbio_2021_05_023
crossref_primary_10_1016_j_nantod_2022_101555
crossref_primary_10_1002_adhm_202100090
crossref_primary_10_1016_j_biomaterials_2023_122434
crossref_primary_10_1021_jacs_9b12936
crossref_primary_10_1016_j_cej_2021_132600
crossref_primary_10_1126_sciadv_abq0997
crossref_primary_10_1039_D4CS00679H
crossref_primary_10_1166_jbn_2021_3055
crossref_primary_10_2174_1568026620666200819160213
crossref_primary_10_1038_s41413_021_00180_y
crossref_primary_10_1039_D4CC04512B
Cites_doi 10.3390/ijms150916057
10.1002/anie.201805664
10.1002/anie.201712027
10.1021/acsnano.7b02533
10.3382/ps.0601355
10.1016/j.ccell.2015.12.010
10.3389/fonc.2012.00088
10.18632/oncotarget.5095
10.1093/jnci/djs629
10.1002/anie.201600234
10.1200/JCO.2014.56.2736
10.1158/1078-0432.CCR-05-1966
10.1021/acsnano.7b00715
10.3389/fimmu.2018.02981
10.2147/OTT.S105862
10.1158/0008-5472.CAN-07-5259
10.1158/2326-6066.CIR-17-0055
10.1021/acsnano.7b03290
10.1016/j.vaccine.2018.07.038
10.1002/adma.201703588
10.1189/jlb.71.3.538
10.1007/s11010-014-2252-7
10.1158/2159-8290.CD-18-0367
10.1021/acsnano.5b08130
10.1084/jem.189.9.1363
10.1517/17425247.3.2.205
10.18632/oncotarget.13475
10.1182/blood-2013-04-497446
10.3389/fimmu.2018.01499
10.1002/adhm.201700467
10.1039/C8BM00588E
10.1002/adma.201505678
10.1038/nnano.2017.57
10.1016/j.cell.2011.09.024
10.1002/adfm.201802847
10.1002/adma.201704408
10.1038/nm.2830
10.1038/s41388-017-0095-x
10.1039/C2CS35265F
10.1074/jbc.270.27.16221
10.1039/C8NR05803B
10.1038/s41467-017-02191-y
10.1038/nmat3355
10.1038/s41586-018-0705-y
10.1016/j.it.2012.10.007
10.1038/s41551-018-0203-4
10.1021/acs.molpharmaceut.8b00126
10.1038/nbt.3330
10.1002/adfm.201804688
10.1002/adma.201805007
10.1016/j.cytogfr.2013.01.005
10.1186/s12929-017-0317-0
10.1039/C8OB02391C
10.1021/acsami.7b16118
10.1016/j.biomaterials.2014.07.024
10.1007/BF02256427
10.1111/ecc.12446
10.1039/C1CS15080D
10.1039/C8DT02941E
10.1038/ncomms13193
10.1038/nmat4822
10.1038/s41467-018-05118-3
10.1007/s00262-015-1771-8
10.1118/1.4888714
10.1016/j.canlet.2017.11.014
10.3389/fimmu.2016.00249
10.1002/adma.200800921
10.1056/NEJMoa1112824
10.1158/1078-0432.CCR-09-2891
10.1039/C5CS00798D
10.1039/C5CC06767G
10.1097/JTO.0b013e318174e9a7
10.1016/j.biomaterials.2017.07.001
10.1038/s41467-018-03705-y
10.1016/j.jconrel.2015.12.006
10.1002/jbio.201600271
10.1021/acs.molpharmaceut.6b01021
10.1186/2051-1426-2-21
10.1038/nrc1071
10.1016/j.biomaterials.2018.09.021
10.1016/j.ctrv.2015.03.011
10.1016/j.ctrv.2018.10.011
10.1016/j.coi.2017.07.003
10.1186/s13046-018-0956-3
10.1038/nrclinonc.2016.25
10.1016/j.biomaterials.2013.05.071
10.1021/nn5002112
10.1007/s12094-008-0172-2
10.3390/cancers6031670
10.1385/MB:25:1:37
10.1038/nrc3670
10.1093/annonc/mdr028
10.1021/acsnano.8b07635
10.1038/natrevmats.2017.24
10.1038/ncomms7301
10.1021/acs.bioconjchem.6b00736
10.1016/j.addr.2008.04.013
10.1002/adma.201200776
10.1002/smll.201804131
10.1126/science.1163612
10.1038/356607a0
10.1371/journal.pone.0140265
10.1002/adma.201700996
10.1021/ja304180y
10.1080/02656736.2018.1446221
10.1039/C7NR01460K
10.1016/j.biomaterials.2015.07.031
10.1186/s12929-017-0329-9
10.1080/14737140.2016.1229600
10.1158/2326-6066.CIR-16-0283
10.1002/adma.201503006
10.1126/sciadv.aao1736
10.1016/j.biomaterials.2014.04.073
10.1038/nri2506
10.1038/s41551-018-0236-8
10.1016/j.ymthe.2018.09.005
10.1172/JCI84427
10.1093/annonc/mdq523
10.1200/JCO.2014.59.4358
10.1038/nnano.2016.168
10.1038/ncomms12499
10.1038/nnano.2011.149
10.1016/j.canlet.2016.09.003
10.1039/C7NR04470D
10.1038/cmi.2015.84
10.1016/j.nantod.2017.10.008
10.1038/s41388-017-0024-z
10.1016/j.biomaterials.2011.12.029
10.1158/0008-5472.CAN-12-2236
10.1021/acs.molpharmaceut.7b00015
10.3389/fchem.2014.00105
10.1021/acs.chemmater.7b01329
10.1002/adma.201800202
10.7150/thno.19826
10.1158/1078-0432.CCR-11-2711
10.1038/s41598-018-30106-4
10.1016/j.biomaterials.2016.11.038
10.1158/1078-0432.CCR-04-2671
10.1021/jacs.8b01072
10.1088/0957-4484/23/7/075102
10.1021/acsnano.5b02829
10.1002/lsm.21080
10.1002/adma.201503280
10.1007/s00262-014-1549-4
10.1016/j.it.2016.01.002
10.1038/nature09737
10.1002/adma.201300081
10.1002/jgm.3015
10.1007/s00262-008-0627-x
10.1016/1074-7613(94)90071-X
10.1038/nature22991
10.1016/j.biomaterials.2016.12.021
10.1021/jacs.6b09538
10.1016/j.addr.2008.03.012
10.1016/j.actbio.2016.10.012
10.1126/scitranslmed.aat7807
10.1056/NEJMoa1003466
10.1021/acsnano.5b07716
10.1101/cshperspect.a028472
10.1158/0008-5472.CAN-18-1351
10.1016/0092-8674(91)90639-G
10.1038/nrclinonc.2017.148
10.1021/nl500618u
10.1038/nrclinonc.2016.211
10.1016/S1470-2045(17)30607-1
10.1056/NEJMoa1001294
10.1080/2162402X.2015.1074374
10.1016/j.coi.2017.01.002
10.1200/JCO.2014.57.3329
10.18632/oncotarget.17663
10.1016/j.biomaterials.2019.01.033
10.1039/C8TB01870G
10.1158/1078-0432.CCR-16-3193
10.1016/j.msec.2015.08.006
10.1016/j.tips.2010.05.003
10.1126/science.aar7112
10.1158/0008-5472.CAN-18-0306
10.1021/acsnano.5b07968
10.3892/etm.2017.4989
10.1097/JTO.0000000000000653
10.3389/fimmu.2018.02375
10.1016/S0169-5002(03)00152-1
10.7150/thno.24387
10.1073/pnas.2232479100
10.1016/j.canlet.2015.01.029
10.1016/j.addr.2016.08.010
10.1002/adma.201402996
10.1002/adfm.201707249
10.1038/nbt.3119
10.1039/C4CS00014E
10.1126/science.271.5256.1734
10.1074/jbc.RA118.002550
10.7150/thno.5284
10.1016/S1470-2045(09)70082-8
10.1039/C6CS00592F
10.1089/jir.2012.0167
10.1038/nnano.2017.52
10.1021/acsnano.5b01324
10.1074/jbc.M114.551879
10.1021/acs.chemrev.5b00125
10.1021/acsnano.5b06860
10.3322/caac.21442
10.1158/0008-5472.CAN-16-0431
10.1038/s41565-018-0146-7
10.1021/acsnano.8b00204
10.1126/science.1214081
10.1002/adma.201803001
10.1007/s10637-014-0092-7
10.1158/2326-6066.IMM2016-A001
10.1002/smll.201703812
10.1039/C3CS60273G
10.1016/j.canlet.2015.05.012
10.1159/000048251
10.1002/adma.201704877
10.1002/smll.201801120
10.1038/nrd.2018.132
10.3389/fonc.2015.00015
10.1002/smll.201601029
10.1002/adfm.201401609
10.2165/00063030-200822020-00001
10.1038/s41578-018-0005-z
10.1038/onc.2009.356
10.1038/emboj.2009.1
10.1016/j.jconrel.2018.11.022
10.1186/s12645-016-0024-7
10.1038/s41467-018-04703-w
10.1021/acsnano.5b07360
10.1039/C8SC02305K
10.1016/j.cellimm.2016.10.004
10.18632/oncotarget.14834
10.1158/0008-5472.CAN-10-2820
10.1021/acsami.5b10056
10.1002/adfm.201804490
10.1146/annurev-med-060512-150254
10.1016/S1470-2045(18)30148-7
10.1016/j.trecan.2016.10.010
10.1073/pnas.94.15.8099
10.1021/nn405701q
10.1097/COC.0b013e3182868ec8
10.1002/advs.201700891
10.7150/ijbs.12852
10.1021/acs.nanolett.6b00599
10.1021/acs.nanolett.8b00040
10.1038/nrc2587
10.1021/acsami.7b18896
10.1002/ijc.31717
10.1002/adfm.201803498
10.1007/s00262-008-0642-y
10.1155/2002/743109
10.1126/science.aaa4967
10.1016/j.gendis.2018.10.003
10.1038/emm.2014.114
10.1038/s41586-018-0768-9
10.1084/jem.183.6.2541
10.1016/j.nantod.2015.06.007
10.1038/s41467-018-03473-9
10.1016/j.ijpharm.2018.08.036
10.1038/s41598-017-09116-1
10.1038/nbt.3071
10.1172/JCI44490
10.1038/nri1457
10.1016/j.immuni.2016.05.001
10.1016/j.biomaterials.2016.09.034
10.1038/cdd.2013.84
10.1038/nrc3958
10.1039/C8NR05323E
10.1016/j.actbio.2013.12.050
10.1126/science.aaa6204
10.1111/bjh.15694
10.4161/onci.23431
10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y
10.1021/acs.nanolett.6b01994
10.1016/j.ijpharm.2018.11.008
10.1016/j.biomaterials.2019.01.003
10.4049/jimmunol.1500751
10.1021/nn202774x
10.1002/smll.201802403
10.1016/j.addr.2011.01.010
10.1021/acs.chemrev.7b00258
10.1016/S1470-2045(15)00007-8
10.1021/acs.nanolett.6b01432
10.1039/C7BM01082F
10.1021/acs.nanolett.6b03329
10.1158/2326-6066.CIR-15-0064
10.1016/j.immuni.2014.06.010
10.1016/j.cell.2018.09.035
10.1016/j.biomaterials.2016.04.034
10.3390/ijms19123949
10.1126/science.aar6711
10.1073/pnas.1505799112
10.1007/s00109-016-1393-4
10.1016/j.biomaterials.2017.09.014
10.1039/C7CS00877E
10.1200/JCO.2013.53.0105
10.1158/1078-0432.CCR-15-0515
10.1038/nrclinonc.2014.111
10.18632/oncotarget.2998
10.1016/j.jconrel.2016.01.042
10.1038/nrc1590
10.1126/scitranslmed.aar1916
10.1021/acsami.8b18751
10.3892/ijmm.2013.1514
10.1016/j.ultrasmedbio.2009.11.005
10.7150/thno.24157
10.1038/s41467-018-04605-x
10.1038/nature23270
10.1111/j.1349-7006.2003.tb01438.x
10.1038/s41563-018-0147-9
10.1038/nnano.2017.113
10.1186/s12967-015-0397-0
10.1021/acsami.6b12792
10.1021/acsami.8b05876
10.1126/science.aaa8172
10.1038/gt.2017.62
10.1002/jps.23356
10.3389/fimmu.2018.02922
10.1158/0008-5472.CAN-12-3058
10.1002/adma.201703969
10.1016/S0140-6736(17)33326-3
10.3389/fimmu.2013.00138
10.1038/nri3191
10.1038/sj.cgt.7700912
10.1039/C3RA47370H
10.1016/j.biomaterials.2013.12.024
10.1007/s11912-018-0712-z
10.1038/nature14292
10.2147/OTT.S171019
10.1038/s41551-018-0262-6
10.1039/C8NH00307F
10.1038/leu.2016.254
10.1016/j.jconrel.2018.04.002
10.1158/0008-5472.CAN-09-0547
10.1021/acs.nanolett.8b02720
10.1016/j.jtho.2016.11.1844
10.1016/S0016-5085(11)60870-6
10.1038/s41588-018-0289-3
10.1038/s41388-018-0241-0
10.1016/j.carbpol.2018.11.049
10.1146/annurev-med-092012-112807
10.1186/1471-244X-12-2
10.1021/acs.nanolett.8b03096
10.1038/s41467-017-01050-0
10.1084/jem.182.2.459
10.2217/nnm.12.11
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2019
Copyright_xml – notice: Copyright Royal Society of Chemistry 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7SP
7SR
8BQ
8FD
JG9
L7M
7X8
7S9
L.6
DOI 10.1039/c8cs00896e
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Electronics & Communications Abstracts
Engineered Materials Abstracts
METADEX
Technology Research Database
Materials Research Database
Advanced Technologies Database with Aerospace
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
Advanced Technologies Database with Aerospace
METADEX
Electronics & Communications Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE
Materials Research Database

CrossRef
AGRICOLA
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1460-4744
EndPage 381
ExternalDocumentID 31165801
10_1039_C8CS00896E
c8cs00896e
Genre Journal Article
Review
GroupedDBID ---
-DZ
-JG
-~X
0-7
0R~
29B
2WC
4.4
53G
5GY
6J9
705
70~
7~J
85S
AAEMU
AAHBH
AAIWI
AAJAE
AAMEH
AANOJ
AAWGC
AAXHV
AAXPP
ABASK
ABDVN
ABEMK
ABJNI
ABPDG
ABRYZ
ABXOH
ACGFO
ACGFS
ACIWK
ACLDK
ACNCT
ADMRA
ADSRN
AEFDR
AENEX
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFRDS
AFVBQ
AGEGJ
AGKEF
AGRSR
AGSTE
AHGCF
ALMA_UNASSIGNED_HOLDINGS
ANUXI
APEMP
ASKNT
AUDPV
AZFZN
BLAPV
BSQNT
C6K
COF
CS3
DU5
EBS
ECGLT
EE0
EF-
EJD
F5P
GGIMP
GNO
H13
HZ~
H~N
IDZ
J3I
M4U
N9A
O9-
OK1
P2P
R7B
R7D
RAOCF
RCNCU
RNS
RPMJG
RRA
RRC
RSCEA
SKA
SKH
SLH
TN5
TWZ
UPT
VH6
WH7
~02
AAYXX
AFRZK
AKMSF
ALUYA
CITATION
R56
CGR
CUY
CVF
ECM
EIF
NPM
7SP
7SR
8BQ
8FD
JG9
L7M
7X8
7S9
L.6
ID FETCH-LOGICAL-c436t-ebb9f1b2984bb1d7636dac241b7b7402dddfd6add16cb66cc790ed4242df70dd3
ISSN 0306-0012
1460-4744
IngestDate Thu Jul 10 18:32:19 EDT 2025
Fri Jul 11 11:14:30 EDT 2025
Mon Jun 30 03:23:59 EDT 2025
Thu Apr 03 07:10:18 EDT 2025
Thu Apr 24 22:58:43 EDT 2025
Tue Jul 01 04:18:42 EDT 2025
Tue Dec 17 21:00:04 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 14
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c436t-ebb9f1b2984bb1d7636dac241b7b7402dddfd6add16cb66cc790ed4242df70dd3
Notes Dr Yunlu Dai is an assistant professor in the Faculty of Health Sciences, University of Macau. He received his PhD degree in 2014 from the Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences, under the supervision of Prof. Jun Lin. Then he moved to the University of Melbourne as a research fellow with Prof. Frank Caruso. In 2016, he joined Dr Xiaoyuan (Shawn) Chen's Laboratory in the National Institutes of Health (NIH) as a postdoctoral fellow. He initiated his independent research program in 2018 at the University of Macau. His research focuses on multifunctional hybrid nanomaterials for cancer theranostics.
diagnostics
index = 128, total citations >59 000 based on Google Scholar) and numerous books and book chapters. He is the founding editor of the journal
in vitro
Wei Sang received her BSc degree from Guangdong Pharmaceutical University in 2015. Then she studied in the Institute of Chinese Medical Sciences/State Key Laboratory of Quality Research in Chinese Medicine in the University of Macau, China, and received her Master of Science degree. She then joined as a PhD student in the research group of Dr Yunlu Dai in the Faculty of Health Sciences, University of Macau, China, in 2018. Her research interests include nanomaterials for cancer immunotherapy and biological imaging.
Zhan Zhang, as a seven-year program student, received his MD degree (2018) in surgery from Dalian Medical University, under the supervision of Prof. Liming Wang. He is currently a PhD student with Dr Yunlu Dai in the Faculty of Health Sciences at the University of Macau. His research interests mainly focus on modifying metal-organic frameworks and metal-phenolic nanoparticles for drug delivery, bioimaging and cancer therapy.
Dr Xiaoyuan (Shawn) Chen is a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. His current research interests include
H
in vivo
molecular imaging and molecular therapeutics, including nanotheranostics. Dr Chen has published over 750 peer-reviewed papers
(2017 IF = 8.537).
Theranostics
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-4023-7320
0000-0002-9622-0870
PMID 31165801
PQID 2257731158
PQPubID 2047503
PageCount 4
ParticipantIDs crossref_citationtrail_10_1039_C8CS00896E
proquest_miscellaneous_2258158335
rsc_primary_c8cs00896e
pubmed_primary_31165801
crossref_primary_10_1039_C8CS00896E
proquest_miscellaneous_2286848927
proquest_journals_2257731158
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20190715
PublicationDateYYYYMMDD 2019-07-15
PublicationDate_xml – month: 7
  year: 2019
  text: 20190715
  day: 15
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Chemical Society reviews
PublicationTitleAlternate Chem Soc Rev
PublicationYear 2019
Publisher Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
References Wu (C8CS00896E-(cit170)/*[position()=1]) 2017; 47
Burnette (C8CS00896E-(cit192)/*[position()=1]) 2011; 71
Galluzzi (C8CS00896E-(cit29)/*[position()=1]) 2018; 10
Chen (C8CS00896E-(cit247)/*[position()=1]) 2003; 25
Zhou (C8CS00896E-(cit351)/*[position()=1]) 2016; 10
Ren (C8CS00896E-(cit180)/*[position()=1]) 2018; 28
Dean (C8CS00896E-(cit14)/*[position()=1]) 2005; 5
Barker (C8CS00896E-(cit212)/*[position()=1]) 2015; 15
Yang (C8CS00896E-(cit350)/*[position()=1]) 2018; 9
Rigotti (C8CS00896E-(cit150)/*[position()=1]) 1995; 270
Postow (C8CS00896E-(cit214)/*[position()=1]) 2012; 366
Peng (C8CS00896E-(cit236)/*[position()=1]) 2018; 5
Barrett (C8CS00896E-(cit316)/*[position()=1]) 2014; 65
Barnett (C8CS00896E-(cit211)/*[position()=1]) 2009; 9
Smith (C8CS00896E-(cit318)/*[position()=1]) 2017; 12
Qiao (C8CS00896E-(cit184)/*[position()=1]) 2016; 94
Fouladi (C8CS00896E-(cit158)/*[position()=1]) 2017; 28
van den Heuvel (C8CS00896E-(cit185)/*[position()=1]) 2015; 13
Coulie (C8CS00896E-(cit254)/*[position()=1]) 2014; 14
Tseng (C8CS00896E-(cit107)/*[position()=1]) 2016; 10
Munn (C8CS00896E-(cit44)/*[position()=1]) 2018; 78
Tabor (C8CS00896E-(cit113)/*[position()=1]) 2018; 3
Conniot (C8CS00896E-(cit91)/*[position()=1]) 2014; 2
Kuai (C8CS00896E-(cit174)/*[position()=1]) 2018; 4
von Halling Laier (C8CS00896E-(cit281)/*[position()=1]) 2018; 550
Song (C8CS00896E-(cit198)/*[position()=1]) 2018; 18
Tsou (C8CS00896E-(cit46)/*[position()=1]) 2016; 76
Guo (C8CS00896E-(cit101)/*[position()=1]) 2018; 9
Oh (C8CS00896E-(cit277)/*[position()=1]) 2017; 8
Mi (C8CS00896E-(cit116)/*[position()=1]) 2016; 7
Liu (C8CS00896E-(cit123)/*[position()=1]) 2016; 97
Wang (C8CS00896E-(cit18)/*[position()=1]) 2018; 17
Zheng (C8CS00896E-(cit262)/*[position()=1]) 2016; 12
Varypataki (C8CS00896E-(cit287)/*[position()=1]) 2017; 5
Twymansaint (C8CS00896E-(cit194)/*[position()=1]) 2015; 520
Gu (C8CS00896E-(cit353)/*[position()=1]) 2012; 24
Tufail (C8CS00896E-(cit250)/*[position()=1]) 2018; 293
Kosmides (C8CS00896E-(cit131)/*[position()=1]) 2017; 118
Wang (C8CS00896E-(cit66)/*[position()=1]) 2017; 112
Dudek (C8CS00896E-(cit17)/*[position()=1]) 2013; 24
Zhang (C8CS00896E-(cit282)/*[position()=1]) 2017; 14
Zang (C8CS00896E-(cit21)/*[position()=1]) 2018; 5
Fan (C8CS00896E-(cit259)/*[position()=1]) 2017; 117
Liu (C8CS00896E-(cit54)/*[position()=1]) 2017; 26
Song (C8CS00896E-(cit122)/*[position()=1]) 2015; 27
Guan (C8CS00896E-(cit311)/*[position()=1]) 2019; 293
Kasturi (C8CS00896E-(cit232)/*[position()=1]) 2011; 470
Le Mercier (C8CS00896E-(cit233)/*[position()=1]) 2013; 73
Shi (C8CS00896E-(cit7)/*[position()=1]) 2016; 12
Chen (C8CS00896E-(cit160)/*[position()=1]) 2018; 28
Zheng (C8CS00896E-(cit171)/*[position()=1]) 2016; 16
Patlolla (C8CS00896E-(cit149)/*[position()=1]) 2015; 399
Teixeiro (C8CS00896E-(cit279)/*[position()=1]) 2009; 323
Deng (C8CS00896E-(cit139)/*[position()=1]) 2018; 9
Feng (C8CS00896E-(cit177)/*[position()=1]) 2018; 30
Li (C8CS00896E-(cit341)/*[position()=1]) 2018; 8
Ginn (C8CS00896E-(cit298)/*[position()=1]) 2018; 20
Chanmee (C8CS00896E-(cit199)/*[position()=1]) 2014; 6
Gao (C8CS00896E-(cit15)/*[position()=1]) 2012; 7
Chao (C8CS00896E-(cit340)/*[position()=1]) 2018; 2
Yata (C8CS00896E-(cit219)/*[position()=1]) 2017; 146
Jin (C8CS00896E-(cit288)/*[position()=1]) 2018; 36
Dixon (C8CS00896E-(cit240)/*[position()=1]) 2018; 50
Ng (C8CS00896E-(cit257)/*[position()=1]) 2018; 28
Qu (C8CS00896E-(cit31)/*[position()=1]) 2017; 11
Dai (C8CS00896E-(cit258)/*[position()=1]) 2017; 46
Yeung (C8CS00896E-(cit263)/*[position()=1]) 2017; 14
Wang (C8CS00896E-(cit267)/*[position()=1]) 2016; 9
Hou (C8CS00896E-(cit264)/*[position()=1]) 2018; 143
Khalil (C8CS00896E-(cit57)/*[position()=1]) 2016; 13
Capella (C8CS00896E-(cit296)/*[position()=1]) 2003; 10
Tu (C8CS00896E-(cit325)/*[position()=1]) 2018; 11
Li (C8CS00896E-(cit32)/*[position()=1]) 2017; 9
Wrangle (C8CS00896E-(cit81)/*[position()=1]) 2018; 19
Wu (C8CS00896E-(cit349)/*[position()=1]) 2018; 10
Dolmans (C8CS00896E-(cit261)/*[position()=1]) 2003; 3
Allemani (C8CS00896E-(cit2)/*[position()=1]) 2018; 391
Lan (C8CS00896E-(cit272)/*[position()=1]) 2018; 140
Park (C8CS00896E-(cit65)/*[position()=1]) 2012; 11
Leach (C8CS00896E-(cit69)/*[position()=1]) 1996; 271
He (C8CS00896E-(cit343)/*[position()=1]) 2016; 7
Li (C8CS00896E-(cit89)/*[position()=1]) 2016; 5
El-Saghire (C8CS00896E-(cit191)/*[position()=1]) 2013; 32
Kroll (C8CS00896E-(cit310)/*[position()=1]) 2017; 29
Ma (C8CS00896E-(cit336)/*[position()=1]) 2014; 41
Zhang (C8CS00896E-(cit355)/*[position()=1]) 2015; 112
Gu (C8CS00896E-(cit280)/*[position()=1]) 2019; 554
Heo (C8CS00896E-(cit323)/*[position()=1]) 2014; 10
Zheng (C8CS00896E-(cit130)/*[position()=1]) 2018; 185
Yuba (C8CS00896E-(cit111)/*[position()=1]) 2017; 120
Taylor (C8CS00896E-(cit356)/*[position()=1]) 2016
Yuba (C8CS00896E-(cit109)/*[position()=1]) 2014; 35
Yue (C8CS00896E-(cit241)/*[position()=1]) 2013; 34
Doehn (C8CS00896E-(cit94)/*[position()=1]) 2008; 22
Wilgenhof (C8CS00896E-(cit86)/*[position()=1]) 2011; 22
Izzedine (C8CS00896E-(cit87)/*[position()=1]) 2014; 32
Tao (C8CS00896E-(cit118)/*[position()=1]) 2014; 35
Kleinovink (C8CS00896E-(cit286)/*[position()=1]) 2016; 22
Slowing (C8CS00896E-(cit126)/*[position()=1]) 2008; 60
Cai (C8CS00896E-(cit252)/*[position()=1]) 2018; 47
Hou (C8CS00896E-(cit5)/*[position()=1]) 2016; 10
Cheung (C8CS00896E-(cit103)/*[position()=1]) 2015; 10
Syn (C8CS00896E-(cit78)/*[position()=1]) 2017; 18
Milosevic (C8CS00896E-(cit202)/*[position()=1]) 2012; 18
Dai (C8CS00896E-(cit155)/*[position()=1]) 2018; 30
Bekisz (C8CS00896E-(cit58)/*[position()=1]) 2013; 33
Henze (C8CS00896E-(cit201)/*[position()=1]) 2016; 126
Krummel (C8CS00896E-(cit229)/*[position()=1]) 1995; 182
Warashina (C8CS00896E-(cit321)/*[position()=1]) 2016; 225
Chen (C8CS00896E-(cit27)/*[position()=1]) 2016; 7
Lin (C8CS00896E-(cit334)/*[position()=1]) 2018; 57
Gabrilovich (C8CS00896E-(cit20)/*[position()=1]) 2009; 9
Li (C8CS00896E-(cit164)/*[position()=1]) 2017; 11
Kumar (C8CS00896E-(cit220)/*[position()=1]) 2015; 57
Juarranz (C8CS00896E-(cit291)/*[position()=1]) 2008; 10
Yuan (C8CS00896E-(cit293)/*[position()=1]) 2013; 102
Zhao (C8CS00896E-(cit143)/*[position()=1]) 2016; 222
Ahmad (C8CS00896E-(cit156)/*[position()=1]) 2014; 4
Kuai (C8CS00896E-(cit173)/*[position()=1]) 2017; 16
Son (C8CS00896E-(cit144)/*[position()=1]) 2014; 15
Noy (C8CS00896E-(cit200)/*[position()=1]) 2014; 41
Luby (C8CS00896E-(cit140)/*[position()=1]) 2017; 113
Qiao (C8CS00896E-(cit181)/*[position()=1]) 2003; 41
Keca (C8CS00896E-(cit4)/*[position()=1]) 2016; 55
Harding (C8CS00896E-(cit70)/*[position()=1]) 1992; 356
Teng (C8CS00896E-(cit80)/*[position()=1]) 2018; 414
Liang (C8CS00896E-(cit182)/*[position()=1]) 2019; 197
Sharabi (C8CS00896E-(cit189)/*[position()=1]) 2015; 16
Zhang (C8CS00896E-(cit197)/*[position()=1]) 2018; 18
Formenti (C8CS00896E-(cit213)/*[position()=1]) 2009; 10
Tang (C8CS00896E-(cit333)/*[position()=1]) 2019; 58
Mellor (C8CS00896E-(cit203)/*[position()=1]) 2004; 4
Munn (C8CS00896E-(cit204)/*[position()=1]) 1999; 189
Walunas (C8CS00896E-(cit230)/*[position()=1]) 1994; 1
Pang (C8CS00896E-(cit6)/*[position()=1]) 2016; 10
Conlon (C8CS00896E-(cit68)/*[position()=1]) 2015; 33
Zanganeh (C8CS00896E-(cit331)/*[position()=1]) 2016; 11
Bloom (C8CS00896E-(cit169)/*[position()=1]) 1981; 60
Ni (C8CS00896E-(cit338)/*[position()=1]) 2018; 9
Hashiguchi (C8CS00896E-(cit337)/*[position()=1]) 2002; 62
Walunas (C8CS00896E-(cit73)/*[position()=1]) 1996; 183
Wang (C8CS00896E-(cit324)/*[position()=1]) 2018; 28
Hokland (C8CS00896E-(cit22)/*[position()=1]) 2018; 183
Di Giacomo (C8CS00896E-(cit88)/*[position()=1]) 2009; 58
Chuang (C8CS00896E-(cit249)/*[position()=1]) 2002; 71
Ghaemi (C8CS00896E-(cit119)/*[position()=1]) 2016; 8
Spicer (C8CS00896E-(cit134)/*[position()=1]) 2018; 47
Boussiotis (C8CS00896E-(cit55)/*[position()=1]) 2018; 37
Song (C8CS00896E-(cit114)/*[position()=1]) 2017; 29
He (C8CS00896E-(cit137)/*[position()=1]) 2015; 115
Cortesi (C8CS00896E-(cit30)/*[position()=1]) 2018; 9
Czapar (C8CS00896E-(cit135)/*[position()=1]) 2016; 10
Yan (C8CS00896E-(cit225)/*[position()=1]) 2019; 11
Wei (C8CS00896E-(cit19)/*[position()=1]) 2018; 8
Grosso (C8CS00896E-(cit75)/*[position()=1]) 2013; 13
Zhu (C8CS00896E-(cit309)/*[position()=1]) 2017; 8
Bol (C8CS00896E-(cit38)/*[position()=1]) 2013; 2
Sahin (C8CS00896E-(cit28)/*[position()=1]) 2018; 359
Borrego (C8CS00896E-(cit36)/*[position()=1]) 2016; 7
Manguso (C8CS00896E-(cit306)/*[position()=1]) 2017; 547
Kumar (C8CS00896E-(cit329)/*[position()=1]) 2008; 68
Yang (C8CS00896E-(cit348)/*[position()=1]) 2017; 8
Naylor (C8CS00896E-(cit246)/*[position()=1]) 2017; 10
Kinjyo (C8CS00896E-(cit278)/*[position()=1]) 2015; 6
Casey (C8CS00896E-(cit327)/*[position()=1]) 2010; 36
Sun (C8CS00896E-(cit41)/*[position()=1]) 2017; 8
Cao (C8CS00896E-(cit265)/*[position()=1]) 2018; 6
Emens (C8CS00896E-(cit166)/*[position()=1]) 2015; 3
He (C8CS00896E-(cit151)/*[position()=1]) 2019; 15
Yuen (C8CS00896E-(cit47)/*[position()=1]) 2016; 2
Wilson (C8CS00896E-(cit295)/*[position()=1]) 2002; 16
Kwon (C8CS00896E-(cit72)/*[position()=1]) 1997; 94
Deng (C8CS00896E-(cit297)/*[position()=1]) 2017; 24
Maeda (C8CS00896E-(cit59)/*[position()=1]) 2014; 289
Oberli (C8CS00896E-(cit322)/*[position()=1]) 2017; 17
Valastyan (C8CS00896E-(cit12)/*[position()=1]) 2011; 147
Restifo (C8CS00896E-(cit255)/*[position()=1]) 2012; 12
Douglas (C8CS00896E-(cit354)/*[position()=1]) 2012; 335
Wu (C8CS00896E-(cit138)/*[position()=1]) 2018; 6
Llevot (C8CS00896E-(cit124)/*[position()=1]) 2012; 41
Wrona (C8CS00896E-(cit300)/*[position()=1]) 2018; 71
Su (C8CS00896E-(cit115)/*[position()=1]) 2014; 11
Hansen (C8CS00896E-(cit147)/*[position()=1]) 2015; 9
Weiss (C8CS00896E-(cit183)/*[position()=1]) 2016; 16
Ektate (C8CS00896E-(cit326)/*[position()=1]) 2018; 8
Li (C8CS00896E-(cit133)/*[position()=1]) 2011; 5
Al Zaki (C8CS00896E-(cit117)/*[position()=1]) 2014; 8
Kharkwal (C8CS00896E-(cit292)/*[position()=1]) 2011; 43
Golden (C8CS00896E-(cit215)/*[position()=1]) 2012; 2
Ganesh (C8CS00896E-(cit312)/*[position()=1]) 2018; 26
Okamoto (C8CS00896E-(cit205)/*[position()=1]) 2005; 11
Cantley (C8CS00896E-(cit299)/*[position()=1]) 1991; 64
Page (C8CS00896E-(cit217)/*[position()=1]) 2014;
References_xml – issn: 2004
  publication-title: Assay Guidance Manual
  doi: Strovel Sittampalam Coussens Hughes Inglese Kurtz Andalibi Patton Austin Baltezor Beckloff Weingarten Weir
– issn: 2016
  end-page: p 1-33
  publication-title: Pharmaceuticals in the Environment
  doi: Taylor
– volume: 15
  start-page: 16057
  year: 2014
  ident: C8CS00896E-(cit144)/*[position()=1]
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms150916057
– volume: 58
  start-page: 946
  year: 2019
  ident: C8CS00896E-(cit333)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201805664
– volume: 57
  start-page: 4902
  year: 2018
  ident: C8CS00896E-(cit334)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201712027
– volume: 11
  start-page: 7006
  year: 2017
  ident: C8CS00896E-(cit164)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.7b02533
– volume: 60
  start-page: 1355
  year: 1981
  ident: C8CS00896E-(cit169)/*[position()=1]
  publication-title: Poult. Sci.
  doi: 10.3382/ps.0601355
– volume: 29
  start-page: 3
  year: 2016
  ident: C8CS00896E-(cit51)/*[position()=1]
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.12.010
– volume: 2
  start-page: 88
  year: 2012
  ident: C8CS00896E-(cit215)/*[position()=1]
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2012.00088
– volume: 6
  start-page: 19346
  year: 2015
  ident: C8CS00896E-(cit34)/*[position()=1]
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.5095
– volume: 105
  start-page: 256
  year: 2013
  ident: C8CS00896E-(cit218)/*[position()=1]
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/djs629
– volume: 55
  start-page: 6187
  year: 2016
  ident: C8CS00896E-(cit4)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201600234
– volume: 33
  start-page: 1889
  year: 2015
  ident: C8CS00896E-(cit274)/*[position()=1]
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2014.56.2736
– volume: 12
  start-page: 1144
  year: 2006
  ident: C8CS00896E-(cit206)/*[position()=1]
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-05-1966
– volume: 11
  start-page: 4463
  year: 2017
  ident: C8CS00896E-(cit275)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.7b00715
– volume: 9
  start-page: 2981
  year: 2018
  ident: C8CS00896E-(cit82)/*[position()=1]
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.02981
– volume: 9
  start-page: 5023
  year: 2016
  ident: C8CS00896E-(cit267)/*[position()=1]
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S105862
– volume: 68
  start-page: 1777
  year: 2008
  ident: C8CS00896E-(cit329)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-5259
– volume: 5
  start-page: 832
  year: 2017
  ident: C8CS00896E-(cit276)/*[position()=1]
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-17-0055
– volume: 11
  start-page: 7293
  year: 2017
  ident: C8CS00896E-(cit31)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.7b03290
– volume: 36
  start-page: 5235
  year: 2018
  ident: C8CS00896E-(cit288)/*[position()=1]
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2018.07.038
– volume: 29
  start-page: 1703588
  year: 2017
  ident: C8CS00896E-(cit235)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201703588
– volume: 71
  start-page: 538
  year: 2002
  ident: C8CS00896E-(cit249)/*[position()=1]
  publication-title: J. Leukocyte Biol.
  doi: 10.1189/jlb.71.3.538
– volume: 399
  start-page: 257
  year: 2015
  ident: C8CS00896E-(cit149)/*[position()=1]
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-014-2252-7
– volume: 8
  start-page: 1069
  year: 2018
  ident: C8CS00896E-(cit19)/*[position()=1]
  publication-title: Cancer Discovery
  doi: 10.1158/2159-8290.CD-18-0367
– volume: 10
  start-page: 5809
  year: 2016
  ident: C8CS00896E-(cit107)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b08130
– volume: 189
  start-page: 1363
  year: 1999
  ident: C8CS00896E-(cit204)/*[position()=1]
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.189.9.1363
– volume: 3
  start-page: 205
  year: 2006
  ident: C8CS00896E-(cit142)/*[position()=1]
  publication-title: Expert Opin. Drug Delivery
  doi: 10.1517/17425247.3.2.205
– volume: 8
  start-page: 8921
  year: 2017
  ident: C8CS00896E-(cit50)/*[position()=1]
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.13475
– volume: 122
  start-page: 3160
  year: 2013
  ident: C8CS00896E-(cit40)/*[position()=1]
  publication-title: Blood
  doi: 10.1182/blood-2013-04-497446
– volume: 9
  start-page: 1499
  year: 2018
  ident: C8CS00896E-(cit101)/*[position()=1]
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.01499
– volume: 6
  start-page: 1700467
  year: 2017
  ident: C8CS00896E-(cit10)/*[position()=1]
  publication-title: Adv. Healthcare Mater.
  doi: 10.1002/adhm.201700467
– volume: 6
  start-page: 2714
  year: 2018
  ident: C8CS00896E-(cit138)/*[position()=1]
  publication-title: Biomater. Sci.
  doi: 10.1039/C8BM00588E
– volume: 28
  start-page: 3987
  year: 2016
  ident: C8CS00896E-(cit25)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201505678
– volume: 13
  start-page: 5
  year: 2013
  ident: C8CS00896E-(cit75)/*[position()=1]
  publication-title: Cancer Immunol.
– volume: 12
  start-page: 813
  year: 2017
  ident: C8CS00896E-(cit318)/*[position()=1]
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2017.57
– volume: 147
  start-page: 275
  year: 2011
  ident: C8CS00896E-(cit12)/*[position()=1]
  publication-title: Cell
  doi: 10.1016/j.cell.2011.09.024
– volume: 28
  start-page: 1802847
  year: 2018
  ident: C8CS00896E-(cit324)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201802847
– volume: 30
  start-page: 1704408
  year: 2018
  ident: C8CS00896E-(cit251)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201704408
– volume: 18
  start-page: 1224
  year: 2012
  ident: C8CS00896E-(cit60)/*[position()=1]
  publication-title: Nat. Med.
  doi: 10.1038/nm.2830
– volume: 37
  start-page: 2165
  year: 2018
  ident: C8CS00896E-(cit49)/*[position()=1]
  publication-title: Oncogene
  doi: 10.1038/s41388-017-0095-x
– volume: 42
  start-page: 1147
  year: 2013
  ident: C8CS00896E-(cit128)/*[position()=1]
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C2CS35265F
– volume: 270
  start-page: 16221
  year: 1995
  ident: C8CS00896E-(cit150)/*[position()=1]
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.27.16221
– volume: 10
  start-page: 16738
  year: 2018
  ident: C8CS00896E-(cit268)/*[position()=1]
  publication-title: Nanoscale
  doi: 10.1039/C8NR05803B
– volume: 8
  start-page: 1954
  year: 2017
  ident: C8CS00896E-(cit309)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-02191-y
– volume: 11
  start-page: 895
  year: 2012
  ident: C8CS00896E-(cit65)/*[position()=1]
  publication-title: Nat. Mater.
  doi: 10.1038/nmat3355
– volume: 564
  start-page: 439
  year: 2018
  ident: C8CS00896E-(cit304)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/s41586-018-0705-y
– volume: 34
  start-page: 169
  year: 2013
  ident: C8CS00896E-(cit45)/*[position()=1]
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2012.10.007
– volume: 2
  start-page: 600
  year: 2018
  ident: C8CS00896E-(cit209)/*[position()=1]
  publication-title: Nat. Biomed. Eng.
  doi: 10.1038/s41551-018-0203-4
– volume: 15
  start-page: 3717
  year: 2018
  ident: C8CS00896E-(cit346)/*[position()=1]
  publication-title: Mol. Pharmaceutics
  doi: 10.1021/acs.molpharmaceut.8b00126
– volume: 33
  start-page: 941
  year: 2015
  ident: C8CS00896E-(cit141)/*[position()=1]
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3330
– volume: 28
  start-page: 1804688
  year: 2018
  ident: C8CS00896E-(cit257)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201804688
– volume: 30
  start-page: 1805007
  year: 2018
  ident: C8CS00896E-(cit308)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201805007
– volume: 24
  start-page: 319
  year: 2013
  ident: C8CS00896E-(cit17)/*[position()=1]
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/j.cytogfr.2013.01.005
– volume: 24
  start-page: 10
  year: 2017
  ident: C8CS00896E-(cit63)/*[position()=1]
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-017-0317-0
– volume: 16
  start-page: 8613
  year: 2018
  ident: C8CS00896E-(cit335)/*[position()=1]
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/C8OB02391C
– volume: 9
  start-page: 43538
  year: 2017
  ident: C8CS00896E-(cit127)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.7b16118
– volume: 35
  start-page: 8992
  year: 2014
  ident: C8CS00896E-(cit120)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2014.07.024
– volume: 10
  start-page: 361
  year: 2003
  ident: C8CS00896E-(cit296)/*[position()=1]
  publication-title: J. Biomed. Sci.
  doi: 10.1007/BF02256427
– volume: 26
  start-page: e12446
  year: 2017
  ident: C8CS00896E-(cit54)/*[position()=1]
  publication-title: Eur. J. Cancer Care
  doi: 10.1111/ecc.12446
– volume: 41
  start-page: 242
  year: 2012
  ident: C8CS00896E-(cit124)/*[position()=1]
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C1CS15080D
– volume: 47
  start-page: 16329
  year: 2018
  ident: C8CS00896E-(cit252)/*[position()=1]
  publication-title: Dalton Trans.
  doi: 10.1039/C8DT02941E
– volume: 7
  start-page: 13193
  year: 2016
  ident: C8CS00896E-(cit27)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms13193
– volume: 16
  start-page: 489
  year: 2017
  ident: C8CS00896E-(cit173)/*[position()=1]
  publication-title: Nat. Mater.
  doi: 10.1038/nmat4822
– volume: 9
  start-page: 2713
  year: 2018
  ident: C8CS00896E-(cit139)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-05118-3
– volume: 65
  start-page: 779
  year: 2016
  ident: C8CS00896E-(cit190)/*[position()=1]
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-015-1771-8
– volume: 41
  start-page: 312
  year: 2014
  ident: C8CS00896E-(cit336)/*[position()=1]
  publication-title: Med. Phys.
  doi: 10.1118/1.4888714
– volume: 414
  start-page: 166
  year: 2018
  ident: C8CS00896E-(cit80)/*[position()=1]
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2017.11.014
– volume: 7
  start-page: 249
  year: 2016
  ident: C8CS00896E-(cit36)/*[position()=1]
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2016.00249
– volume: 20
  start-page: 3832
  year: 2008
  ident: C8CS00896E-(cit26)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.200800921
– volume: 366
  start-page: 925
  year: 2012
  ident: C8CS00896E-(cit214)/*[position()=1]
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1112824
– volume: 16
  start-page: 3100
  year: 2010
  ident: C8CS00896E-(cit16)/*[position()=1]
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-09-2891
– volume: 45
  start-page: 1457
  year: 2016
  ident: C8CS00896E-(cit108)/*[position()=1]
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C5CS00798D
– volume: 51
  start-page: 15752
  year: 2015
  ident: C8CS00896E-(cit163)/*[position()=1]
  publication-title: Chem. Commun.
  doi: 10.1039/C5CC06767G
– volume: 3
  start-page: S164
  year: 2008
  ident: C8CS00896E-(cit96)/*[position()=1]
  publication-title: J. Thorac. Oncol.
  doi: 10.1097/JTO.0b013e318174e9a7
– volume: 141
  start-page: 272
  year: 2017
  ident: C8CS00896E-(cit110)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2017.07.001
– volume: 11
  start-page: 86
  year: 2014
  ident: C8CS00896E-(cit115)/*[position()=1]
  publication-title: Cancer Biol. Med.
– volume: 9
  start-page: 1410
  year: 2018
  ident: C8CS00896E-(cit146)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-03705-y
– volume: 222
  start-page: 56
  year: 2016
  ident: C8CS00896E-(cit143)/*[position()=1]
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2015.12.006
– volume: 10
  start-page: 618
  year: 2017
  ident: C8CS00896E-(cit246)/*[position()=1]
  publication-title: J. Biophotonics
  doi: 10.1002/jbio.201600271
– volume: 14
  start-page: 1494
  year: 2017
  ident: C8CS00896E-(cit77)/*[position()=1]
  publication-title: Mol. Pharmaceutics
  doi: 10.1021/acs.molpharmaceut.6b01021
– volume: 2
  start-page: 21
  year: 2014
  ident: C8CS00896E-(cit208)/*[position()=1]
  publication-title: J. Immunother. Cancer
  doi: 10.1186/2051-1426-2-21
– volume: 3
  start-page: 380
  year: 2003
  ident: C8CS00896E-(cit261)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1071
– volume: 185
  start-page: 133
  year: 2018
  ident: C8CS00896E-(cit130)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2018.09.021
– volume: 41
  start-page: 503
  year: 2015
  ident: C8CS00896E-(cit196)/*[position()=1]
  publication-title: Cancer Treat. Rev.
  doi: 10.1016/j.ctrv.2015.03.011
– volume: 71
  start-page: 59
  year: 2018
  ident: C8CS00896E-(cit300)/*[position()=1]
  publication-title: Cancer Treat. Rev.
  doi: 10.1016/j.ctrv.2018.10.011
– volume: 47
  start-page: 57
  year: 2017
  ident: C8CS00896E-(cit92)/*[position()=1]
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2017.07.003
– volume: 37
  start-page: 284
  year: 2018
  ident: C8CS00896E-(cit48)/*[position()=1]
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-018-0956-3
– volume: 13
  start-page: 273
  year: 2016
  ident: C8CS00896E-(cit57)/*[position()=1]
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2016.25
– volume: 34
  start-page: 6853
  year: 2013
  ident: C8CS00896E-(cit241)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.05.071
– volume: 8
  start-page: 5670
  year: 2014
  ident: C8CS00896E-(cit221)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/nn5002112
– volume: 10
  start-page: 148
  year: 2008
  ident: C8CS00896E-(cit291)/*[position()=1]
  publication-title: Clin. Transl. Oncol.
  doi: 10.1007/s12094-008-0172-2
– volume: 6
  start-page: 1670
  year: 2014
  ident: C8CS00896E-(cit199)/*[position()=1]
  publication-title: Cancers
  doi: 10.3390/cancers6031670
– volume: 25
  start-page: 37
  year: 2003
  ident: C8CS00896E-(cit247)/*[position()=1]
  publication-title: Mol. Biotechnol.
  doi: 10.1385/MB:25:1:37
– volume: 14
  start-page: 135
  year: 2014
  ident: C8CS00896E-(cit254)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3670
– volume: 22
  start-page: 991
  year: 2011
  ident: C8CS00896E-(cit86)/*[position()=1]
  publication-title: Ann. Oncol.
  doi: 10.1093/annonc/mdr028
– volume: 12
  start-page: 11819
  year: 2018
  ident: C8CS00896E-(cit330)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b07635
– volume: 2
  start-page: 17024
  year: 2017
  ident: C8CS00896E-(cit153)/*[position()=1]
  publication-title: Nat. Rev. Mater.
  doi: 10.1038/natrevmats.2017.24
– volume: 6
  start-page: 6301
  year: 2015
  ident: C8CS00896E-(cit278)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms7301
– volume: 28
  start-page: 857
  year: 2017
  ident: C8CS00896E-(cit158)/*[position()=1]
  publication-title: Bioconjugate Chem.
  doi: 10.1021/acs.bioconjchem.6b00736
– volume: 60
  start-page: 1329
  year: 2008
  ident: C8CS00896E-(cit106)/*[position()=1]
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/j.addr.2008.04.013
– volume: 24
  start-page: 3981
  year: 2012
  ident: C8CS00896E-(cit353)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201200776
– volume: 15
  start-page: 1804131
  year: 2019
  ident: C8CS00896E-(cit151)/*[position()=1]
  publication-title: Small
  doi: 10.1002/smll.201804131
– volume: 323
  start-page: 502
  year: 2009
  ident: C8CS00896E-(cit279)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.1163612
– volume: 46
  start-page: 6387
  year: 1986
  ident: C8CS00896E-(cit145)/*[position()=1]
  publication-title: Cancer Res.
– volume: 356
  start-page: 607
  year: 1992
  ident: C8CS00896E-(cit70)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/356607a0
– volume: 10
  start-page: e0140265
  year: 2015
  ident: C8CS00896E-(cit342)/*[position()=1]
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0140265
– volume: 29
  start-page: 1700996
  year: 2017
  ident: C8CS00896E-(cit114)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201700996
– volume: 134
  start-page: 11358
  year: 2012
  ident: C8CS00896E-(cit227)/*[position()=1]
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja304180y
– volume: 34
  start-page: 1337
  year: 2018
  ident: C8CS00896E-(cit244)/*[position()=1]
  publication-title: Int. J. Hyperthermia
  doi: 10.1080/02656736.2018.1446221
– volume: 9
  start-page: 5927
  year: 2017
  ident: C8CS00896E-(cit248)/*[position()=1]
  publication-title: Nanoscale
  doi: 10.1039/C7NR01460K
– volume: 67
  start-page: 214
  year: 2015
  ident: C8CS00896E-(cit112)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2015.07.031
– volume: 24
  start-page: 26
  year: 2017
  ident: C8CS00896E-(cit76)/*[position()=1]
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-017-0329-9
– volume: 16
  start-page: 1087
  year: 2016
  ident: C8CS00896E-(cit183)/*[position()=1]
  publication-title: Expert Rev. Anticancer Ther.
  doi: 10.1080/14737140.2016.1229600
– volume: 5
  start-page: 222
  year: 2017
  ident: C8CS00896E-(cit287)/*[position()=1]
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-16-0283
– volume: 27
  start-page: 6110
  year: 2015
  ident: C8CS00896E-(cit122)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201503006
– volume: 4
  start-page: eaao1736
  year: 2018
  ident: C8CS00896E-(cit174)/*[position()=1]
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aao1736
– volume: 35
  start-page: 6646
  year: 2014
  ident: C8CS00896E-(cit118)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2014.04.073
– volume: 9
  start-page: 162
  year: 2009
  ident: C8CS00896E-(cit20)/*[position()=1]
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2506
– volume: 2
  start-page: 578
  year: 2018
  ident: C8CS00896E-(cit105)/*[position()=1]
  publication-title: Nat. Biomed. Eng.
  doi: 10.1038/s41551-018-0236-8
– volume: 26
  start-page: 2567
  year: 2018
  ident: C8CS00896E-(cit312)/*[position()=1]
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2018.09.005
– volume: 126
  start-page: 3672
  year: 2016
  ident: C8CS00896E-(cit201)/*[position()=1]
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI84427
– volume: 21
  start-page: 250
  year: 2010
  ident: C8CS00896E-(cit289)/*[position()=1]
  publication-title: Ann. Oncol.
  doi: 10.1093/annonc/mdq523
– volume: 33
  start-page: 1974
  year: 2015
  ident: C8CS00896E-(cit84)/*[position()=1]
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2014.59.4358
– volume: 11
  start-page: 986
  year: 2016
  ident: C8CS00896E-(cit331)/*[position()=1]
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2016.168
– volume: 7
  start-page: 12499
  year: 2016
  ident: C8CS00896E-(cit343)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms12499
– volume: 6
  start-page: 675
  year: 2011
  ident: C8CS00896E-(cit352)/*[position()=1]
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2011.149
– volume: 382
  start-page: 255
  year: 2016
  ident: C8CS00896E-(cit42)/*[position()=1]
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2016.09.003
– volume: 9
  start-page: 13413
  year: 2017
  ident: C8CS00896E-(cit32)/*[position()=1]
  publication-title: Nanoscale
  doi: 10.1039/C7NR04470D
– volume: 14
  start-page: 223
  year: 2017
  ident: C8CS00896E-(cit263)/*[position()=1]
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/cmi.2015.84
– volume: 17
  start-page: 23
  year: 2017
  ident: C8CS00896E-(cit11)/*[position()=1]
  publication-title: Nano Today
  doi: 10.1016/j.nantod.2017.10.008
– volume: 37
  start-page: 1121
  year: 2018
  ident: C8CS00896E-(cit55)/*[position()=1]
  publication-title: Oncogene
  doi: 10.1038/s41388-017-0024-z
– volume: 33
  start-page: 3235
  year: 2012
  ident: C8CS00896E-(cit243)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2011.12.029
– volume: 72
  start-page: 5483
  year: 2012
  ident: C8CS00896E-(cit167)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-2236
– volume: 14
  start-page: 1760
  year: 2017
  ident: C8CS00896E-(cit282)/*[position()=1]
  publication-title: Mol. Pharmaceutics
  doi: 10.1021/acs.molpharmaceut.7b00015
– volume: 2
  start-page: 105
  year: 2014
  ident: C8CS00896E-(cit91)/*[position()=1]
  publication-title: Front. Chem.
  doi: 10.3389/fchem.2014.00105
– volume: 29
  start-page: 4580
  year: 2017
  ident: C8CS00896E-(cit159)/*[position()=1]
  publication-title: Chem. Mater.
  doi: 10.1021/acs.chemmater.7b01329
– volume: 30
  start-page: 1800202
  year: 2018
  ident: C8CS00896E-(cit152)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201800202
– volume: 8
  start-page: 860
  year: 2018
  ident: C8CS00896E-(cit341)/*[position()=1]
  publication-title: Theranostics
  doi: 10.7150/thno.19826
– volume: 18
  start-page: 2108
  year: 2012
  ident: C8CS00896E-(cit202)/*[position()=1]
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-11-2711
– volume: 8
  start-page: 13062
  year: 2018
  ident: C8CS00896E-(cit326)/*[position()=1]
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-30106-4
– volume: 118
  start-page: 16
  year: 2017
  ident: C8CS00896E-(cit131)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.11.038
– volume: 11
  start-page: 6030
  year: 2005
  ident: C8CS00896E-(cit205)/*[position()=1]
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-04-2671
– volume: 140
  start-page: 5670
  year: 2018
  ident: C8CS00896E-(cit272)/*[position()=1]
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.8b01072
– volume: 23
  start-page: 075102
  year: 2012
  ident: C8CS00896E-(cit228)/*[position()=1]
  publication-title: Nanotechnology
  doi: 10.1088/0957-4484/23/7/075102
– volume: 9
  start-page: 6861
  year: 2015
  ident: C8CS00896E-(cit53)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b02829
– volume: 43
  start-page: 755
  year: 2011
  ident: C8CS00896E-(cit292)/*[position()=1]
  publication-title: Lasers Surg. Med.
  doi: 10.1002/lsm.21080
– volume: 27
  start-page: 7692
  year: 2015
  ident: C8CS00896E-(cit24)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201503280
– volume: 63
  start-page: 721
  year: 2014
  ident: C8CS00896E-(cit237)/*[position()=1]
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-014-1549-4
– volume: 37
  start-page: 193
  year: 2016
  ident: C8CS00896E-(cit238)/*[position()=1]
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2016.01.002
– volume: 8
  start-page: 304
  year: 2017
  ident: C8CS00896E-(cit62)/*[position()=1]
  publication-title: Front. Immunol.
– volume: 470
  start-page: 543
  year: 2011
  ident: C8CS00896E-(cit232)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/nature09737
– volume: 25
  start-page: 2641
  year: 2013
  ident: C8CS00896E-(cit8)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201300081
– volume: 20
  start-page: e3015
  year: 2018
  ident: C8CS00896E-(cit298)/*[position()=1]
  publication-title: J. Gene Med.
  doi: 10.1002/jgm.3015
– volume: 58
  start-page: 1351
  year: 2009
  ident: C8CS00896E-(cit85)/*[position()=1]
  publication-title: Cancer Immunol.
  doi: 10.1007/s00262-008-0627-x
– volume: 1
  start-page: 405
  year: 1994
  ident: C8CS00896E-(cit230)/*[position()=1]
  publication-title: J. Immunity
  doi: 10.1016/1074-7613(94)90071-X
– volume: 547
  start-page: 217
  year: 2017
  ident: C8CS00896E-(cit99)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/nature22991
– volume: 120
  start-page: 32
  year: 2017
  ident: C8CS00896E-(cit111)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.12.021
– volume: 138
  start-page: 16686
  year: 2016
  ident: C8CS00896E-(cit271)/*[position()=1]
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.6b09538
– volume: 60
  start-page: 1278
  year: 2008
  ident: C8CS00896E-(cit126)/*[position()=1]
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/j.addr.2008.03.012
– volume: 47
  start-page: 81
  year: 2017
  ident: C8CS00896E-(cit170)/*[position()=1]
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2016.10.012
– volume: 10
  start-page: eaat7807
  year: 2018
  ident: C8CS00896E-(cit29)/*[position()=1]
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aat7807
– volume: 363
  start-page: 711
  year: 2010
  ident: C8CS00896E-(cit74)/*[position()=1]
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1003466
– volume: 10
  start-page: 2678
  year: 2016
  ident: C8CS00896E-(cit351)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b07716
– volume: 10
  start-page: a028472
  year: 2018
  ident: C8CS00896E-(cit33)/*[position()=1]
  publication-title: Cold Spring Harbor Perspect. Biol.
  doi: 10.1101/cshperspect.a028472
– volume: 78
  start-page: 5191
  year: 2018
  ident: C8CS00896E-(cit44)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-1351
– volume: 62
  start-page: 1604
  year: 2002
  ident: C8CS00896E-(cit266)/*[position()=1]
  publication-title: Cancer Res.
– volume: 64
  start-page: 281
  year: 1991
  ident: C8CS00896E-(cit299)/*[position()=1]
  publication-title: Cell
  doi: 10.1016/0092-8674(91)90639-G
– volume: 15
  start-page: 47
  year: 2017
  ident: C8CS00896E-(cit315)/*[position()=1]
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2017.148
– volume: 14
  start-page: 2181
  year: 2014
  ident: C8CS00896E-(cit136)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/nl500618u
– volume: 14
  start-page: 365
  year: 2017
  ident: C8CS00896E-(cit195)/*[position()=1]
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2016.211
– volume: 18
  start-page: e731
  year: 2017
  ident: C8CS00896E-(cit78)/*[position()=1]
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(17)30607-1
– volume: 363
  start-page: 411
  year: 2010
  ident: C8CS00896E-(cit93)/*[position()=1]
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1001294
– volume: 5
  start-page: e1074374
  year: 2016
  ident: C8CS00896E-(cit89)/*[position()=1]
  publication-title: OncoImmunology
  doi: 10.1080/2162402X.2015.1074374
– volume: 45
  start-page: 43
  year: 2017
  ident: C8CS00896E-(cit35)/*[position()=1]
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2017.01.002
– volume: 33
  start-page: 74
  year: 2015
  ident: C8CS00896E-(cit68)/*[position()=1]
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2014.57.3329
– volume: 8
  start-page: 47440
  year: 2017
  ident: C8CS00896E-(cit277)/*[position()=1]
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.17663
– volume: 197
  start-page: 368
  year: 2019
  ident: C8CS00896E-(cit182)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2019.01.033
– volume: 6
  start-page: 6122
  year: 2018
  ident: C8CS00896E-(cit253)/*[position()=1]
  publication-title: J. Mater. Chem. B
  doi: 10.1039/C8TB01870G
– volume: 23
  start-page: 4190
  year: 2017
  ident: C8CS00896E-(cit148)/*[position()=1]
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-3193
– volume: 57
  start-page: 321
  year: 2015
  ident: C8CS00896E-(cit220)/*[position()=1]
  publication-title: Mater. Sci. Eng., C
  doi: 10.1016/j.msec.2015.08.006
– volume: 31
  start-page: 356
  year: 2010
  ident: C8CS00896E-(cit64)/*[position()=1]
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2010.05.003
– volume: 359
  start-page: 1355
  year: 2018
  ident: C8CS00896E-(cit28)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.aar7112
– volume: 78
  start-page: 3718
  year: 2018
  ident: C8CS00896E-(cit319)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-0306
– volume: 10
  start-page: 3121
  year: 2016
  ident: C8CS00896E-(cit6)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b07968
– volume: 14
  start-page: 3399
  year: 2017
  ident: C8CS00896E-(cit284)/*[position()=1]
  publication-title: Exp. Ther. Med.
  doi: 10.3892/etm.2017.4989
– volume: 10
  start-page: 1458
  year: 2015
  ident: C8CS00896E-(cit186)/*[position()=1]
  publication-title: J. Thorac. Oncol.
  doi: 10.1097/JTO.0000000000000653
– volume: 9
  start-page: 2375
  year: 2018
  ident: C8CS00896E-(cit30)/*[position()=1]
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.02375
– volume: 41
  start-page: 1
  year: 2003
  ident: C8CS00896E-(cit181)/*[position()=1]
  publication-title: Lung Cancer
  doi: 10.1016/S0169-5002(03)00152-1
– volume: 8
  start-page: 4238
  year: 2018
  ident: C8CS00896E-(cit100)/*[position()=1]
  publication-title: Theranostics
  doi: 10.7150/thno.24387
– volume: 100
  start-page: 13549
  year: 2003
  ident: C8CS00896E-(cit234)/*[position()=1]
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.2232479100
– volume: 359
  start-page: 169
  year: 2015
  ident: C8CS00896E-(cit242)/*[position()=1]
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2015.01.029
– volume: 113
  start-page: 97
  year: 2017
  ident: C8CS00896E-(cit140)/*[position()=1]
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/j.addr.2016.08.010
– volume: 26
  start-page: 8154
  year: 2014
  ident: C8CS00896E-(cit231)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201402996
– volume: 28
  start-page: 1707249
  year: 2018
  ident: C8CS00896E-(cit273)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201707249
– volume: 33
  start-page: 44
  year: 2015
  ident: C8CS00896E-(cit23)/*[position()=1]
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3119
– volume: 43
  start-page: 6570
  year: 2014
  ident: C8CS00896E-(cit129)/*[position()=1]
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C4CS00014E
– volume: 271
  start-page: 1734
  year: 1996
  ident: C8CS00896E-(cit69)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.271.5256.1734
– volume: 293
  start-page: 11310
  year: 2018
  ident: C8CS00896E-(cit250)/*[position()=1]
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.RA118.002550
– volume: 3
  start-page: 317
  year: 2013
  ident: C8CS00896E-(cit260)/*[position()=1]
  publication-title: Theranostics
  doi: 10.7150/thno.5284
– volume: 10
  start-page: 718
  year: 2009
  ident: C8CS00896E-(cit213)/*[position()=1]
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(09)70082-8
– volume: 46
  start-page: 3830
  year: 2017
  ident: C8CS00896E-(cit258)/*[position()=1]
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C6CS00592F
– volume: 33
  start-page: 154
  year: 2013
  ident: C8CS00896E-(cit58)/*[position()=1]
  publication-title: J. Interferon Cytokine Res.
  doi: 10.1089/jir.2012.0167
– volume: 12
  start-page: 648
  year: 2017
  ident: C8CS00896E-(cit132)/*[position()=1]
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2017.52
– volume: 9
  start-page: 6985
  year: 2015
  ident: C8CS00896E-(cit147)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b01324
– volume: 289
  start-page: 23786
  year: 2014
  ident: C8CS00896E-(cit59)/*[position()=1]
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M114.551879
– volume: 115
  start-page: 11079
  year: 2015
  ident: C8CS00896E-(cit137)/*[position()=1]
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.5b00125
– volume: 10
  start-page: 1417
  year: 2016
  ident: C8CS00896E-(cit5)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b06860
– volume: 6
  start-page: 208
  year: 2015
  ident: C8CS00896E-(cit102)/*[position()=1]
  publication-title: J. Gastrointest. Oncol.
– volume: 68
  start-page: 7
  year: 2018
  ident: C8CS00896E-(cit1)/*[position()=1]
  publication-title: Ca-Cancer J. Clin.
  doi: 10.3322/caac.21442
– volume: 76
  start-page: 5597
  year: 2016
  ident: C8CS00896E-(cit46)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-16-0431
– volume: 13
  start-page: 746
  year: 2018
  ident: C8CS00896E-(cit125)/*[position()=1]
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-018-0146-7
– volume: 12
  start-page: 7647
  year: 2018
  ident: C8CS00896E-(cit245)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b00204
– volume: 335
  start-page: 831
  year: 2012
  ident: C8CS00896E-(cit354)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.1214081
– volume: 30
  start-page: 1803001
  year: 2018
  ident: C8CS00896E-(cit177)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201803001
– volume: 32
  start-page: 769
  year: 2014
  ident: C8CS00896E-(cit87)/*[position()=1]
  publication-title: Invest. New Drugs
  doi: 10.1007/s10637-014-0092-7
– volume: 4
  start-page: A001
  year: 2016
  ident: C8CS00896E-(cit52)/*[position()=1]
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.IMM2016-A001
– volume: 14
  start-page: 1703812
  year: 2018
  ident: C8CS00896E-(cit165)/*[position()=1]
  publication-title: Small
  doi: 10.1002/smll.201703812
– volume: 43
  start-page: 744
  year: 2014
  ident: C8CS00896E-(cit154)/*[position()=1]
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C3CS60273G
– volume: 365
  start-page: 23
  year: 2015
  ident: C8CS00896E-(cit193)/*[position()=1]
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2015.05.012
– volume: 62
  start-page: 85
  year: 2002
  ident: C8CS00896E-(cit337)/*[position()=1]
  publication-title: Oncology
  doi: 10.1159/000048251
– volume: 30
  start-page: 1704877
  year: 2018
  ident: C8CS00896E-(cit155)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201704877
– volume: 14
  start-page: 1801120
  year: 2018
  ident: C8CS00896E-(cit168)/*[position()=1]
  publication-title: Small
  doi: 10.1002/smll.201801120
– volume: 17
  start-page: 751
  year: 2018
  ident: C8CS00896E-(cit320)/*[position()=1]
  publication-title: Nat. Rev. Drug Discovery
  doi: 10.1038/nrd.2018.132
– volume-title: Assay Guidance Manual
  year: 2004
  ident: C8CS00896E-(cit357)/*[position()=1]
– volume: 5
  start-page: 15
  year: 2015
  ident: C8CS00896E-(cit285)/*[position()=1]
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2015.00015
– volume: 12
  start-page: 3995
  year: 2016
  ident: C8CS00896E-(cit7)/*[position()=1]
  publication-title: Small
  doi: 10.1002/smll.201601029
– volume: 24
  start-page: 6613
  year: 2014
  ident: C8CS00896E-(cit121)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201401609
– volume: 29
  start-page: 1
  year: 2018
  ident: C8CS00896E-(cit303)/*[position()=1]
  publication-title: Artif. Cells, Nanomed., Biotechnol.
– volume: 22
  start-page: 71
  year: 2008
  ident: C8CS00896E-(cit94)/*[position()=1]
  publication-title: BioDrugs
  doi: 10.2165/00063030-200822020-00001
– volume: 3
  start-page: 5
  year: 2018
  ident: C8CS00896E-(cit113)/*[position()=1]
  publication-title: Nat. Rev. Mater.
  doi: 10.1038/s41578-018-0005-z
– volume: 29
  start-page: 482
  year: 2009
  ident: C8CS00896E-(cit175)/*[position()=1]
  publication-title: Oncogene
  doi: 10.1038/onc.2009.356
– volume: 28
  start-page: 578
  year: 2014
  ident: C8CS00896E-(cit283)/*[position()=1]
  publication-title: EMBO J.
  doi: 10.1038/emboj.2009.1
– volume: 293
  start-page: 104
  year: 2019
  ident: C8CS00896E-(cit311)/*[position()=1]
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2018.11.022
– volume: 7
  start-page: 11
  year: 2016
  ident: C8CS00896E-(cit116)/*[position()=1]
  publication-title: Cancer Nanotechnol.
  doi: 10.1186/s12645-016-0024-7
– volume: 9
  start-page: 2351
  year: 2018
  ident: C8CS00896E-(cit338)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-04703-w
– volume: 10
  start-page: 4119
  year: 2016
  ident: C8CS00896E-(cit135)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b07360
– volume: 9
  start-page: 7210
  year: 2018
  ident: C8CS00896E-(cit350)/*[position()=1]
  publication-title: Chem. Sci.
  doi: 10.1039/C8SC02305K
– volume: 311
  start-page: 54
  year: 2017
  ident: C8CS00896E-(cit104)/*[position()=1]
  publication-title: Cell. Immunol.
  doi: 10.1016/j.cellimm.2016.10.004
– volume: 8
  start-page: 15168
  year: 2017
  ident: C8CS00896E-(cit41)/*[position()=1]
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14834
– volume: 71
  start-page: 2488
  year: 2011
  ident: C8CS00896E-(cit192)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-2820
– volume: 8
  start-page: 3123
  year: 2016
  ident: C8CS00896E-(cit119)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.5b10056
– volume: 28
  start-page: 1804490
  year: 2018
  ident: C8CS00896E-(cit180)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201804490
– volume: 65
  start-page: 333
  year: 2014
  ident: C8CS00896E-(cit316)/*[position()=1]
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev-med-060512-150254
– volume: 19
  start-page: 694
  year: 2018
  ident: C8CS00896E-(cit81)/*[position()=1]
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(18)30148-7
– volume: 2
  start-page: 747
  year: 2016
  ident: C8CS00896E-(cit47)/*[position()=1]
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2016.10.010
– volume: 94
  start-page: 8099
  year: 1997
  ident: C8CS00896E-(cit72)/*[position()=1]
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.94.15.8099
– volume: 8
  start-page: 104
  year: 2014
  ident: C8CS00896E-(cit117)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/nn405701q
– volume: 38
  start-page: 90
  year: 2015
  ident: C8CS00896E-(cit216)/*[position()=1]
  publication-title: Am. J. Clin. Oncol.
  doi: 10.1097/COC.0b013e3182868ec8
– volume: 5
  start-page: 1700891
  year: 2018
  ident: C8CS00896E-(cit236)/*[position()=1]
  publication-title: Adv. Sci.
  doi: 10.1002/advs.201700891
– volume: 12
  start-page: 120
  year: 2016
  ident: C8CS00896E-(cit262)/*[position()=1]
  publication-title: Int. J. Biol. Sci.
  doi: 10.7150/ijbs.12852
– volume: 27
  start-page: 1
  year: 2018
  ident: C8CS00896E-(cit90)/*[position()=1]
  publication-title: J. Obstet. Gynaecol.
– volume: 16
  start-page: 3202
  year: 2016
  ident: C8CS00896E-(cit3)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.6b00599
– volume: 18
  start-page: 2475
  year: 2018
  ident: C8CS00896E-(cit269)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.8b00040
– volume: 9
  start-page: 134
  year: 2009
  ident: C8CS00896E-(cit211)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2587
– volume: 10
  start-page: 6942
  year: 2018
  ident: C8CS00896E-(cit349)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.7b18896
– volume: 143
  start-page: 3050
  year: 2018
  ident: C8CS00896E-(cit264)/*[position()=1]
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31717
– volume: 28
  start-page: 1803498
  year: 2018
  ident: C8CS00896E-(cit160)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201803498
– volume: 58
  start-page: 1297
  year: 2009
  ident: C8CS00896E-(cit88)/*[position()=1]
  publication-title: Cancer Immunol.
  doi: 10.1007/s00262-008-0642-y
– volume: 16
  start-page: 393
  year: 2002
  ident: C8CS00896E-(cit295)/*[position()=1]
  publication-title: Can. J. Gastroenterol.
  doi: 10.1155/2002/743109
– volume: 7
  start-page: 691
  year: 2015
  ident: C8CS00896E-(cit157)/*[position()=1]
  publication-title: Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol.
– volume: 348
  start-page: 62
  year: 2015
  ident: C8CS00896E-(cit314)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.aaa4967
– volume: 5
  start-page: 302
  year: 2018
  ident: C8CS00896E-(cit21)/*[position()=1]
  publication-title: Genes Dis.
  doi: 10.1016/j.gendis.2018.10.003
– volume: 47
  start-page: e141
  year: 2015
  ident: C8CS00896E-(cit37)/*[position()=1]
  publication-title: Exp. Mol. Med.
  doi: 10.1038/emm.2014.114
– volume: 565
  start-page: 43
  year: 2019
  ident: C8CS00896E-(cit307)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/s41586-018-0768-9
– volume: 183
  start-page: 2541
  year: 1996
  ident: C8CS00896E-(cit73)/*[position()=1]
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.183.6.2541
– volume: 10
  start-page: 511
  year: 2015
  ident: C8CS00896E-(cit103)/*[position()=1]
  publication-title: Nano Today
  doi: 10.1016/j.nantod.2015.06.007
– volume: 9
  start-page: 1074
  year: 2018
  ident: C8CS00896E-(cit344)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-03473-9
– volume: 550
  start-page: 35
  year: 2018
  ident: C8CS00896E-(cit281)/*[position()=1]
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2018.08.036
– volume: 7
  start-page: 8606
  year: 2017
  ident: C8CS00896E-(cit226)/*[position()=1]
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-09116-1
– volume: 33
  start-page: 64
  year: 2015
  ident: C8CS00896E-(cit178)/*[position()=1]
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3071
– volume: 121
  start-page: 985
  year: 2011
  ident: C8CS00896E-(cit332)/*[position()=1]
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI44490
– volume: 4
  start-page: 762
  year: 2004
  ident: C8CS00896E-(cit203)/*[position()=1]
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri1457
– volume: 44
  start-page: 989
  year: 2016
  ident: C8CS00896E-(cit239)/*[position()=1]
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.05.001
– volume: 112
  start-page: 153
  year: 2017
  ident: C8CS00896E-(cit66)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.09.034
– volume: 21
  start-page: 39
  year: 2013
  ident: C8CS00896E-(cit176)/*[position()=1]
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2013.84
– volume: 15
  start-page: 409
  year: 2015
  ident: C8CS00896E-(cit212)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3958
– volume: 10
  start-page: 21640
  year: 2018
  ident: C8CS00896E-(cit222)/*[position()=1]
  publication-title: Nanoscale
  doi: 10.1039/C8NR05323E
– volume: 10
  start-page: 2169
  year: 2014
  ident: C8CS00896E-(cit323)/*[position()=1]
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2013.12.050
– volume: 348
  start-page: 74
  year: 2015
  ident: C8CS00896E-(cit187)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.aaa6204
– volume: 183
  start-page: 698
  year: 2018
  ident: C8CS00896E-(cit22)/*[position()=1]
  publication-title: Br. J. Haematol.
  doi: 10.1111/bjh.15694
– volume: 2
  start-page: e23431
  year: 2013
  ident: C8CS00896E-(cit38)/*[position()=1]
  publication-title: OncoImmunology
  doi: 10.4161/onci.23431
– volume: 29
  start-page: 3596
  year: 1999
  ident: C8CS00896E-(cit71)/*[position()=1]
  publication-title: Eur. J. Immunol.
  doi: 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y
– volume: 16
  start-page: 5503
  year: 2016
  ident: C8CS00896E-(cit347)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.6b01994
– volume: 554
  start-page: 72
  year: 2019
  ident: C8CS00896E-(cit280)/*[position()=1]
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2018.11.008
– volume: 195
  start-page: 75
  year: 2019
  ident: C8CS00896E-(cit161)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2019.01.003
– volume: 195
  start-page: 755
  year: 2015
  ident: C8CS00896E-(cit317)/*[position()=1]
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1500751
– volume: 5
  start-page: 8783
  year: 2011
  ident: C8CS00896E-(cit133)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/nn202774x
– volume: 14
  start-page: 1802403
  year: 2018
  ident: C8CS00896E-(cit172)/*[position()=1]
  publication-title: Small
  doi: 10.1002/smll.201802403
– volume: 63
  start-page: 582
  year: 2011
  ident: C8CS00896E-(cit13)/*[position()=1]
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/j.addr.2011.01.010
– volume: 117
  start-page: 13566
  year: 2017
  ident: C8CS00896E-(cit259)/*[position()=1]
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.7b00258
– volume: 16
  start-page: e498
  year: 2015
  ident: C8CS00896E-(cit189)/*[position()=1]
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(15)00007-8
– volume: 16
  start-page: 4341
  year: 2016
  ident: C8CS00896E-(cit171)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.6b01432
– volume: 6
  start-page: 473
  year: 2018
  ident: C8CS00896E-(cit265)/*[position()=1]
  publication-title: Biomater. Sci.
  doi: 10.1039/C7BM01082F
– volume: 17
  start-page: 1326
  year: 2017
  ident: C8CS00896E-(cit322)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.6b03329
– volume: 3
  start-page: 436
  year: 2015
  ident: C8CS00896E-(cit166)/*[position()=1]
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-15-0064
– volume: 41
  start-page: 49
  year: 2014
  ident: C8CS00896E-(cit200)/*[position()=1]
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.06.010
– volume: 175
  start-page: 313
  year: 2018
  ident: C8CS00896E-(cit56)/*[position()=1]
  publication-title: Cell
  doi: 10.1016/j.cell.2018.09.035
– volume: 97
  start-page: 1
  year: 2016
  ident: C8CS00896E-(cit123)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.04.034
– volume: 19
  start-page: 3949
  year: 2018
  ident: C8CS00896E-(cit302)/*[position()=1]
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms19123949
– volume: 359
  start-page: 1361
  year: 2018
  ident: C8CS00896E-(cit313)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.aar6711
– volume: 112
  start-page: E6129
  year: 2015
  ident: C8CS00896E-(cit355)/*[position()=1]
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1505799112
– volume: 94
  start-page: 489
  year: 2016
  ident: C8CS00896E-(cit184)/*[position()=1]
  publication-title: J. Mol. Med.
  doi: 10.1007/s00109-016-1393-4
– volume: 146
  start-page: 136
  year: 2017
  ident: C8CS00896E-(cit219)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2017.09.014
– volume: 47
  start-page: 3574
  year: 2018
  ident: C8CS00896E-(cit134)/*[position()=1]
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C7CS00877E
– volume: 32
  start-page: 1020
  year: 2014
  ident: C8CS00896E-(cit79)/*[position()=1]
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2013.53.0105
– volume: 22
  start-page: 1459
  year: 2016
  ident: C8CS00896E-(cit286)/*[position()=1]
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-0515
– volume: 11
  start-page: 509
  year: 2014
  ident: C8CS00896E-(cit98)/*[position()=1]
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2014.111
– volume: 5
  start-page: 12472
  year: 2014
  ident: C8CS00896E-(cit256)/*[position()=1]
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2998
– volume: 225
  start-page: 183
  year: 2016
  ident: C8CS00896E-(cit321)/*[position()=1]
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2016.01.042
– volume: 5
  start-page: 275
  year: 2005
  ident: C8CS00896E-(cit14)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1590
– volume: 10
  start-page: eaar1916
  year: 2018
  ident: C8CS00896E-(cit179)/*[position()=1]
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aar1916
– volume: 11
  start-page: 1876
  year: 2019
  ident: C8CS00896E-(cit225)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.8b18751
– volume: 32
  start-page: 1407
  year: 2013
  ident: C8CS00896E-(cit191)/*[position()=1]
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.2013.1514
– volume: 36
  start-page: 430
  year: 2010
  ident: C8CS00896E-(cit327)/*[position()=1]
  publication-title: Ultrasound Med. Biol.
  doi: 10.1016/j.ultrasmedbio.2009.11.005
– volume: 8
  start-page: 3490
  year: 2018
  ident: C8CS00896E-(cit67)/*[position()=1]
  publication-title: Theranostics
  doi: 10.7150/thno.24157
– volume: 9
  start-page: 2237
  year: 2018
  ident: C8CS00896E-(cit339)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-04605-x
– volume: 547
  start-page: 413
  year: 2017
  ident: C8CS00896E-(cit306)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/nature23270
– volume: 94
  start-page: 308
  year: 2003
  ident: C8CS00896E-(cit328)/*[position()=1]
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2003.tb01438.x
– volume: 17
  start-page: 761
  year: 2018
  ident: C8CS00896E-(cit18)/*[position()=1]
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-018-0147-9
– volume: 12
  start-page: 877
  year: 2017
  ident: C8CS00896E-(cit210)/*[position()=1]
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2017.113
– volume: 13
  start-page: 32
  year: 2015
  ident: C8CS00896E-(cit185)/*[position()=1]
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-015-0397-0
– volume: 9
  start-page: 6712
  year: 2017
  ident: C8CS00896E-(cit162)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.6b12792
– volume: 10
  start-page: 20342
  year: 2018
  ident: C8CS00896E-(cit223)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.8b05876
– volume-title: Pharmaceuticals in the Environment
  year: 2016
  ident: C8CS00896E-(cit356)/*[position()=1]
– volume: 348
  start-page: 56
  year: 2015
  ident: C8CS00896E-(cit270)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.aaa8172
– volume: 24
  start-page: 572
  year: 2017
  ident: C8CS00896E-(cit297)/*[position()=1]
  publication-title: Gene Ther.
  doi: 10.1038/gt.2017.62
– volume: 102
  start-page: 6
  year: 2013
  ident: C8CS00896E-(cit293)/*[position()=1]
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.23356
– volume: 9
  start-page: 2922
  year: 2018
  ident: C8CS00896E-(cit83)/*[position()=1]
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.02922
– volume: 73
  start-page: 4629
  year: 2013
  ident: C8CS00896E-(cit233)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-3058
– volume: 29
  start-page: 1703969
  year: 2017
  ident: C8CS00896E-(cit310)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201703969
– volume: 391
  start-page: 1023
  year: 2018
  ident: C8CS00896E-(cit2)/*[position()=1]
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)33326-3
– volume: 4
  start-page: 138
  year: 2013
  ident: C8CS00896E-(cit188)/*[position()=1]
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2013.00138
– volume: 12
  start-page: 269
  year: 2012
  ident: C8CS00896E-(cit255)/*[position()=1]
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3191
– volume: 13
  start-page: 335
  year: 2006
  ident: C8CS00896E-(cit305)/*[position()=1]
  publication-title: Cancer Gene Ther.
  doi: 10.1038/sj.cgt.7700912
– volume: 4
  start-page: 17028
  year: 2014
  ident: C8CS00896E-(cit156)/*[position()=1]
  publication-title: RSC Adv.
  doi: 10.1039/C3RA47370H
– volume: 35
  start-page: 3091
  year: 2014
  ident: C8CS00896E-(cit109)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.12.024
– volume: 20
  start-page: 75
  year: 2018
  ident: C8CS00896E-(cit95)/*[position()=1]
  publication-title: Curr. Oncol. Rep.
  doi: 10.1007/s11912-018-0712-z
– volume: 520
  start-page: 373
  year: 2015
  ident: C8CS00896E-(cit194)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/nature14292
– volume: 11
  start-page: 5763
  year: 2018
  ident: C8CS00896E-(cit325)/*[position()=1]
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S171019
– volume: 2
  start-page: 611
  year: 2018
  ident: C8CS00896E-(cit340)/*[position()=1]
  publication-title: Nat. Biomed. Eng.
  doi: 10.1038/s41551-018-0262-6
– volume: 4
  start-page: 426
  year: 2019
  ident: C8CS00896E-(cit9)/*[position()=1]
  publication-title: Nanoscale Horiz.
  doi: 10.1039/C8NH00307F
– volume: 31
  start-page: 697
  year: 2017
  ident: C8CS00896E-(cit97)/*[position()=1]
  publication-title: Leukemia
  doi: 10.1038/leu.2016.254
– volume: 278
  start-page: 87
  year: 2018
  ident: C8CS00896E-(cit224)/*[position()=1]
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2018.04.002
– volume: 69
  start-page: 4941
  year: 2009
  ident: C8CS00896E-(cit43)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-0547
– volume: 18
  start-page: 6360
  year: 2018
  ident: C8CS00896E-(cit198)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.8b02720
– volume: 12
  start-page: S1304
  year: 2017
  ident: C8CS00896E-(cit39)/*[position()=1]
  publication-title: J. Thorac. Oncol.
  doi: 10.1016/j.jtho.2016.11.1844
– volume: 5
  start-page: 673
  year: 2014
  ident: C8CS00896E-(cit207)/*[position()=1]
  publication-title: Front. Immunol.
– volume: 140
  start-page: S215
  year: 2011
  ident: C8CS00896E-(cit290)/*[position()=1]
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(11)60870-6
– volume: 50
  start-page: 1640
  year: 2018
  ident: C8CS00896E-(cit240)/*[position()=1]
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-018-0289-3
– volume: 23
  start-page: 505
  year: 2003
  ident: C8CS00896E-(cit294)/*[position()=1]
  publication-title: Anticancer Res.
– volume: 37
  start-page: 3778
  year: 2018
  ident: C8CS00896E-(cit301)/*[position()=1]
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0241-0
– volume: 206
  start-page: 694
  year: 2019
  ident: C8CS00896E-(cit345)/*[position()=1]
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2018.11.049
– volume: 65
  start-page: 185
  year: 2014
  ident: C8CS00896E-(cit217)/*[position()=1]
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev-med-092012-112807
– volume: 12
  start-page: 2
  year: 2012
  ident: C8CS00896E-(cit61)/*[position()=1]
  publication-title: BMC Psychiatry
  doi: 10.1186/1471-244X-12-2
– volume: 18
  start-page: 7092
  year: 2018
  ident: C8CS00896E-(cit197)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.8b03096
– volume: 8
  start-page: 902
  year: 2017
  ident: C8CS00896E-(cit348)/*[position()=1]
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-01050-0
– volume: 182
  start-page: 459
  year: 1995
  ident: C8CS00896E-(cit229)/*[position()=1]
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.182.2.459
– volume: 7
  start-page: 465
  year: 2012
  ident: C8CS00896E-(cit15)/*[position()=1]
  publication-title: Nanomedicine
  doi: 10.2217/nnm.12.11
SSID ssj0011762
Score 2.6759117
SecondaryResourceType review_article
Snippet In recent years, conventional treatments including surgery, chemotherapy and radiotherapy have been the main approaches in tumour therapy. Cancer immunotherapy...
SourceID proquest
pubmed
crossref
rsc
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3771
SubjectTerms Anticancer properties
antineoplastic activity
biocompatible materials
bioengineering
Biomedical materials
Cancer therapies
Chemotherapy
Combined Modality Therapy
drug therapy
Humans
immune system
Immunotherapy
Materials science
metastasis
Nanomaterials
Nanostructures - chemistry
neoplasms
Neoplasms - immunology
Neoplasms - therapy
patients
precision medicine
Radiation therapy
radiotherapy
surgery
Transformations
Title Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
URI https://www.ncbi.nlm.nih.gov/pubmed/31165801
https://www.proquest.com/docview/2257731158
https://www.proquest.com/docview/2258158335
https://www.proquest.com/docview/2286848927
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVIJeEK-CS0FGcEHIxY_NPo5VFNQi4ACpCCfL-zCKVJwqjQ_01zP7sh2lIOBiWevZONpvvDs7O_MNQq-E0JrXJE1gsa9gg1LrxJTfTjLBscorrqgt2vfxEzk9x-8Xk8VodDaIWmo34lhe35hX8j-oQhvgarJk_wHZ7kehAe4BX7gCwnD9K4zB5rMh4u4c30a2NlWzAiPUvj0xS5QypAR6_d0SMpsIctgKO9Cl6bR-szQZIj4Pa-uMt-MSCJGdnrm0c8p4V_NXvdxxP5ub3gluIwa-tc1F20cTuOlusaxWP1sv650PNt8pcemXx9pNmNjgTB2HY5hRMRtqDh7MjwV1BVd2Ju60MLynkskrMEo40UMhGPTLHxbCwpAFMe_92KbJDo9uob0cdgz5GO2dzOZnH7ojpQym_cBPW_C3_av20e3Qeds42dlxgP2xDnVhrP0xv4fu-o1DfOK04D4a6eYBujMN9foeos9OG-KgDfGyiXe1IR5oQzzQhthpQ7ylDY_Q-bvZfHqa-IoZicQF2SRaCF5nIucMC5EpWDuIqiQYaYIKitNcKVUrAktaRqQgRErKU60wmGmqpqlSxQEaN6tGP0FxToUkouZE1hLnNVgtOp9ogicplnyiVIReh6EqpaeTN1VNLkob1lDwcsqmX-wIzyL0spO9dCQqN0odhREv_Ud2VcJyQ6lhhGIRetE9hpE151pVo1etlWGZzR78kwwjDDOe0wg9dmh2fyWgH6EDgLdr7jXk8LddnqL9_rM4QuPNutXPwErdiOde_34BdaCVpQ
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+advances+in+nanomaterial-based+synergistic+combination+cancer+immunotherapy&rft.jtitle=Chemical+Society+reviews&rft.au=Sang%2C+Wei&rft.au=Zhang%2C+Zhan&rft.au=Dai%2C+Yunlu&rft.au=Chen%2C+Xiaoyuan&rft.date=2019-07-15&rft.eissn=1460-4744&rft.volume=48&rft.issue=14&rft.spage=3771&rft_id=info:doi/10.1039%2Fc8cs00896e&rft_id=info%3Apmid%2F31165801&rft.externalDocID=31165801
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-0012&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-0012&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-0012&client=summon